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The increased demand of real-time and convenient heath monitoring has spurned the 
rapid development of wearable health monitoring devices. In these devices, the central part is 
the sensor that can convert health information into readable data. Biosensors have been 
widely used in this field since they can be easily fit into small devices and provide sensitive 
and selective detections of key health indicators in the human body.  
In this study, we developed a membrane biosensor used to detect lactate. Lactate is a 
significant health indicator. The variations of the lactate level in the human body imply 
physiological changes, such as indicating decubitus ulcers for bedridden people. Our 
membrane biosensor is formed on thin-film gold electrodes. Its working electrode, on which 
lactate oxidase is immobilized, generates a current signal that is related to the lactate 
concentration of the electrolyte solution. The sensor also has a built-in solid-state Ag/AgCl 
electrode that is capable of maintaining a stable potential for hours. The membrane biosensor 
was able to generate reliable and stable signals. Its dynamic detection range was 4 to 30 mM, 
with a detection limit higher than the highest physiological lactate level. To mimic the real 
working scenario for the membrane sensor, it was attached to a transdermal microneedle 
patch and placed inside a sensor-enclosing device. The microneedles are able to pierce the 
human skin and extract interstitial fluid and capillary blood. Body fluids including human 
plasma and whole blood were used to test the sensor. Experimental results revealed that the 
membrane sensor could provide stable and consistent signals in plasma but was unreliable in 
whole blood.  
This master’s thesis demonstrates the feasibility of using a membrane sensor with a 
simple configuration to detect lactate while assembled in a transdermal device, and provides 
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Chapter 1. Background 
1.1 Wearable Health Monitoring Devices 
Nowadays, the entire world is experiencing the increasing cost of public healthcare and 
the aging of the population, which leads to the growing demand of personalized and 
distributed healthcare.1 Various types of wearable health monitoring devices (WHMDs) are 
ideal personalized health monitors. Instead of going to hospitals and waiting in line, patients 
who use WHMDs can acquire low-cost, time-saving and real-time health monitoring (Figure 
1.1).2 During the last few years, tremendous progress has been made in the research and 
commercialization of WHMDs.3,4 One typical example of the commercial WHMDs is the 
GlucoWatch® biographer from Cygnus, Inc. It can be worn on the wrist as a watch and 
monitor the blood sugar level timely.5 Various types of WHMDs have been researched on. 
These smart devices could be built on clothes and contact lenses, and even directly mounted 
on the human skin like a tatto.6–9  
To design and produce WHMDs, there are several basic standards to be met. For 
Figure 1.1. A comparison between centralized healthcare service and portable health monitors. 
Portable health monitors can conduct detection, data collection, signal transmission and 




example, they must be lightweight and have small sizes so that they are comfortable and 
convenient for people to wear; the manufacturing cost of WHMDs should be low.10 Ideally, 
they should be able to complete the whole process, from detecting vital health indicators to 
giving feedback to the users, when applied to the human body (Figure 1.1).2 If the device is 
integrated with a wireless signal transmission system, the users’ health information can be 
sent to their physicians in time.10 With the supervision of WHMDs and physicians in daily 
life, it is possible that the users’ physical conditions can be analyzed in more detail and those 
threats to users’ health can be greatly avoided.   
WHMDs can measure physical, chemical or biological changes of a human body, 
depending on the type of sensors integrated inside the devices. The sensors inside WHMDs 
can be divided into three types: physical sensor, chemical sensor and biosensor. Body 
temperature, heartbeat and respiration rate are physical properties and can be measured by 
piezo-resistive sensors, capacitive sensors and other physical sensors.11 Chemicals in a human 
body are mainly ions, such as H+, Na+ and NH4+. Their levels can be measured by 
potentiometric ion-selective sensors.12–14 To detect biological changes, such as the 
concentration variations of metabolites in the human body, biosensors are required and they 
will be further introduced in the next section. By aggregating various types of sensors in one 
device, one could produce a multipurpose WHMD and obtain a comprehensive view of 
health.15,16 
1.2 Biosensors 
The first idea of the biosensor was put forward in 1962 by Clark and Lyons.17 They 
demonstrated a glucose biosensor where glucose oxidase was trapped between two 
Cuprophane membranes and placed on the surface of a pH electrode. When glucose 
molecules encounter glucose oxidase, they are converted to gluconic acid, resulting into the 
decrease of pH. Thus, the pH value detected by the electrode could represent the glucose 




Biosensors are developed from chemical sensors. A chemical sensor is typically 
composed of a transducer and a signal processing system. The transducer is the key 
component where the conversation of analyte information to displayable signals takes place. 
In the transducer of a chemical sensor, the recognition elements can selectively react with 
analytes and both of them are chemical species.18 While in biosensors, the recognition 
elements are bioreceptors including nucleic acids, cells, antibodies and enzymes (Figure 
1.2).19 The high affinity between analytes and their bioreceptors, such as the base-pairing of 
nucleic acids, antibody-antigen interactions, and enzyme-substrate interactions, gives rise to 
the high selectivity and sensitivity of biosensors.19 The interactions between the analytes and 
bioreceptors could result in various changes in the biosensors. Another component of the 
transducer, which could be potentiometric or amperometric electrodes, optoelectronic 
detectors or field effect transistors, captures these variations and generates relevant signals.20 
Afterwards, the signals are amplified, processed and displayed.19  
Biosensors in WHMDs are mainly used to monitor the metabolites in the body fluids of a 
human, such as glucose, urea and lactate.21–23 This work here focuses on biosensors for lactate 
detection. 
Figure 1.2. Some examples of the elements in a biosensor. A typical electrochemical biosensor 
is composed of a transducer and a signal processing system. The recognition elements in the 




1.3 Physiology and Clinic Significances of Lactate 
Lactate has two isomers, L-(+)-lactate and D-(−)-lactate. It was confirmed by researchers 
that only the L-lactate form was found in mammals.24 All lactate mentioned and used in this 
work is L-lactate.  
Lactate is one product of glucose metabolism. Glucose is consumed in the human body 
to yield adenosine triphosphate (ATP) as the energy supply. Along with the release of energy, 
pyruvate is produced which could generate extra ATP under aerobic conditions in 
mitochondria.25 However, when there is no oxygen or mitochondria, pyruvate will be 
converted to lactic acid by lactate dehydrogenase (LDH). At physiologic pH, most lactic acid 
dissociates to lactate and H+ (Figure 1.3).25 Just like other metabolites, lactate in a human 
body must be produced and consumed properly to maintain a steady state. The clearance of 
lactate is composed of two pathways: it can be converted back to pyruvate and glucose in the 
kidneys, liver and heart, or be excreted by the kidneys.26,27  
The normal range of lactate in the human whole blood is 0.5 to 2.0 mM.23 On account of 
physiological changes, its concentration can rise to about 18 mM.28 The abnormal 
accumulation of lactate in the human body along with the decrease of blood pH is called 
lactic acidosis.25 Both the over production and the reduced consumption of lactate could lead 
to lactic acidosis. In turn, lactic acidosis indicates that the oxygen level in the body might be 
abnormal, or mitochondria, the kidneys, liver and heart might not function appropriately.25-27 
Fluctuations of lactate level can indicate certain physical conditions for both healthy and 
Figure 1.3. The structure of lactic acid and lactate, and the dissociation of lactic acid into 





unhealthy people. For example, the lactate level can increase significantly because of 
exhaustive exercise.29 The blood lactate level has been treated as an indicator for many years 
to grade the endurance capability of athletes and quantify the exercise intensity.30 For 
bedridden people, long-lasting high lactate level in body fluids indicates the lack of oxygen 
within the tissue. In such a case, the lying position of this patient must be adjusted to avoid 
decubitus ulcers.29 For critical patients, the blood lactate level can be an indicator of their 
responses to therapies. The decline of lactate level means a greater chance to survive. 
According to the level variations, physicians can make adjustments to therapy strategies.31  
To conclude, the lactate level in the human body is a significant human health indicator. 
As a result, timely and convenient lactate monitoring is desirable. To fulfill this requirement, 
nowadays, there are many household devices on the market that are designed for lactate 
monitoring. For example, Lactate Pro (LP, Arkray KDK, Japan) and Lactate Plus (L+, Nova 
Biomedical, USA) can detect lactate in whole blood. Lactate Scout (LS, SensLab GmbH, 
Germany) can measure the lactate concentration from 0.5 mM to 25 mM in capillary blood. It 
requires a sample volume of 0.5 μL and a analysis time of 10 s.32 The performance of these 
commercial portable devices has been compared to laboratory analyzers. Although these 
devices are reliable, their accuracies and stabilities must be improved.32,33 
1.4 Principle of Electrochemical Lactate Detection 
 Many WHMDs take advantage of biosensors to detect the health markers in the human 
body. In terms of lactate monitoring, various electrochemical biosensors have been studied.34–
37 An electrochemical biosensor is usually a three-electrode system, consisting of a working 
electrode (WE), a reference electrode (RE) and a counter electrode (CE).38 Figure 1.4 is a 
sketch that describes the construction of a typical three-electrode system.39 During an 
electrochemical experiment, reactions take place on the WE surface, altering its potential and 
forming current. The CE forms a circuit with the WE to enable the current flow while 
measuring its value. Meanwhile, there is no current flowing through the RE and the potential 
of RE keeps fixed. By connecting the WE and RE with a voltmeter, the potential of  WE can 
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be measured quantitatively.38,39 The WE is the transducer of a biosensor and on or near its 
surface there are bioreceptors which can interact with the target analytes and generate 
corresponding electric signals.  
For lactate detection, LDH and lactate oxidase (LOD) are the most widely used 
bioreceptors.40 The principles, merits and demerits of employing LDH and LOD in lactate 
biosensors will be introduced.  
The catalytic reaction carried out by LOD is shown by the equation below:40 
𝐿𝑎𝑐𝑡𝑎𝑡𝑒 + 𝑂2
𝐿𝑂𝐷
→  𝑃𝑦𝑟𝑢𝑣𝑎𝑡𝑒 + 𝐻2𝑂2                                 1.1 
Through this reaction, the detection of lactate can be converted to that of H2O2. The 
detection of H2O2 is based on its oxidation and reduction on an electrode surface. The redox 
reactions of H2O2 are listed below:41 
Oxidation: 𝐻2𝑂2 →𝑂2 + 2𝐻
+ + 2𝑒−                                 1.2 
Reduction: 𝐻2𝑂2 + 2𝐻
+ + 2𝑒− → 2𝐻2𝑂                              1.3 
With more reactions proceeding, current starts to flow between the WE and CE. In cyclic 
voltammetry (CV), both the reduction and oxidation of H2O2 have corresponding peaks. The 
variations of H2O2 concentration are embodied in the changes of peak currents (Ip). Due to the 





stoichiometric relationship between hydrogen peroxide and lactate, the value of Ip is 
proportional to the lactate concentration in the bulk solution.23  
The catalytic reaction carried out by LDH is shown by the equation below:40 
𝐿𝑎𝑐𝑡𝑎𝑡𝑒 + 𝑁𝐴𝐷+
𝐿𝐷𝐻
→  𝑃𝑦𝑟𝑢𝑣𝑎𝑡𝑒 +  𝑁𝐴𝐷𝐻                            1.4 
The NAD+ and NADH are a pair of coenzymes that function as mediators to facilitate 
electron transfer between the electrode and LDH.40 With more lactate molecules being 
consumed by LDH, more electrons will be transferred, and a larger current will be generated.  
The requirement of involving additional enzymes other than LDH complicates the 
construction and maintenance of the biosensors, while the lactate detection with the help of 
LOD is a single-enzyme process.40 However, in the biosensors based on LOD, oxygen is one 
of the reactants and the varying oxygen level around the electrodes can possibly bring 
inaccuracies to the sensors’ detection.40 
According to Rassaei et al., LOD is used generally more than LDH in the research of 
lactate biosensors.40 As a result, when the lactate biosensor in this work was designed, LOD 
was chosen to be the bioreceptor in the transducer.   
1.5 Lactate Biosensors Based on LOD 
Biosensors that detect lactate based on LOD can be further divided into two classes, 
Figure 1.5. (a) CV grams of the Nafion/LOD/ZnO/Au electrode in the PBS with 0.3 mM lactate 
(red) and without lactate (blue). (b) The response curve of the Nafion/LOD/ZnO/Au electrode to 




depending on whether redox mediators are incorporated or not. There are two types of redox 
mediators, which can facilitate the electron transfer between 1) H2O2 and the WE surface; 2) 
LOD and the WE surface.42,43 When redox mediators exist in the biosensors, the current being 
recorded will not be originated from the redox reaction of H2O2. One example of each type of 
lactate biosensor will be presented in this section. 
Figure 1.5 shows one example of the lactate biosensors in which no redox mediator is 
involved. This lactate biosensor, fabricated by Yang et al., consisted of a gold WE that was 
modified with Nafion, ZnO nanotetrapods and LOD.35 This Nafion/LOD/ZnO/Au electrode 
was tested by CV in phosphate-buffered saline (PBS) with and without lactate and the results 
were shown in Figure 1.5a. In the presence of 0.3 mM lactate, an evident peak arose at 0.52 V, 
which was resulted from the redox reaction of H2O2.35 Figure 1.5b is the calibration curve of 
this enzyme electrode. The signal provided by the enzyme electrode, which was the current 
Figure 1.6. (a) The CV grams of the FED in various concentrations of lactate and (b) its 
response curve with an inset showing its linear detection range.43 (c) The CV grams of the 
FcMe2-LPEI/LOx film on a glassy carbon electrode in the PBS with (solid) and without 
(dashed) lactate. (d) The calibration curve of this enzyme electrode (Inset: the lower 
concentration range).42  
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density, increased linearly with the lactate concentration in the range of 3.6 μM to 0.6 mM 
and plateaued after 1.2 mM.35  
The cyclic voltammograms (CV grams) in Figure 1.6a & c were generated by the lactate 
sensors in which redox mediators were incorporated. Comparing to the set of CV grams in 
Figure 1.5a, these two sets of CV grams differ greatly: they are the characteristic CV grams of 
reversible electrochemical reactions and there are background signals when no lactate is 
present.  
Figure 1.6a was generated by a fabric-based electrochemical device (FED).43 The WE 
surface of this FED was modified with Prussian blue (PB) which could transport electrons 
from the WE to H2O2. The signal detected by the FED was generated by the redox reaction of 
PB which was spontaneous and reversible on the WE surface. When the concentration of 
H2O2 increased, more electrons were transported by PB to reduce H2O2, resulting into a larger 
current.43 As shown by the calibration curve of the FED, it had a linear detection range from 
0.1 to 5 mM of lactate and its signal saturated at about 10 mM.43   
The CV grams of a glassy carbon electrode coated with a film in 0 and 40 mM lactate 
solutions are presented in Figure 1.6c.42 The film was composed of dimethylferrocene-
modified linear polyethyleneimine and LOD. This ferrocene-modified polymer could 
facilitate the shuttle of electrons between the active site of LOD and the WE surface.42 When 
more lactate molecules were catalyzed by LOD, more electrons were shuttled and the current 
increased. According to the calibration curve in Figure 1.6d, the signal of this enzyme 
electrode was linear to lactate concentration from 3 μM  to 5 mM and it became saturated 
after 15 mM.42  
As described before, all calibration curves presented in Figure 1.5 and 1.6 possessed 
similar features: the curve rises evidently with increasing lactate concentration in the 
beginning while plateaued after a certain level. In fact, all biosensors based on LOD should 
have this type of calibration curve which can be attributed to enzyme kinetics.  
Michaelis–Menten kinetics is the most commonly used model to describe the enzyme 
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kinetics. In this model, the conversion from the substrate (S) to the product (P) catalyzed by 
the enzyme (E) involved an intermediate stage where S and E forms a complex ES. This 
process can be expressed as follows:  
E + 𝑆 
𝐾𝑜𝑓𝑓
←    
𝐾𝑜𝑛   
→     𝐸𝑆  
𝐾𝑐𝑎𝑡 
→  𝐸 + 𝑃                                               1.5 
Where Kon and Koff are the rates of the binding and unbinding of E and S; Kcat is the rate 
of catalysis.44 Michaelis–Menten equation can be derived from this reaction scheme under 







                                                1.6 
where KM is equal to (Koff + Kcat) / Kon and ʋmax is the maximum formation rate of P.44 KM 
indicates the strength of the binding between the enzyme and the substrates. A lower KM 
means a tighter binding between the enzyme and the substrate which also indicates a less 
effective enzymatic reaction. By plotting this equation, one could get Michaelis–Menten 
saturation curve that shows how the concentration of S affects the P formation rate of an 
enzyme-involved reaction (Figure 1.7).45 It is evident that the shape of the calibration curves 
of the lactate biosensors is similar to this Michaelis–Menten saturation curve. 
Figure 1.7. Michaelis–Menten saturation curve.45  
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Chapter 2. Electrode Fabrication and Modifications 
2.1 Fabrication of Membrane Electrodes 
2.1.1 Electron-beam Physical Vapor Deposition 
Electron-beam physical vapor deposition (EB-PVD) is one technology that can coat a 
thin film of metal or ceramic on various types of substrates.46 The membrane sensor in this 
work is made of thin-film gold electrodes that were fabricated using EB-PVD. The principle 
and advantages of EB-PVD will be briefly introduced. 
The process of EB-PVD is presented in Figure 2.1. In a vacuum chamber, a strong and 
focused electron beam is directed straightly (Figure 2.1a) or bent (Figure 2.1b) to the material 
to be evaporated.46 Taking the high energy from the electron beam, the material would melt, 
evaporate and deposit onto the substrate that is placed above it.46 There could be extra 
electron beams in the chamber for preheating the substrate so that the coating on its surface 
would be more stable.47,48 
Multiple types of materials can be placed in the chamber and be melt by the electron 
beam in sequence. Therefore, multilayer coating can be accomplished by EB-PVD without 
interrupting the vacuum.47 Other significant advantages of EB-PVD can be listed as: having a 
higher deposition rate than other PVD techniques, controlled microstructure and composition, 
low contamination, and a smooth surface finish, etc.47,49  
Figure 2.1. Two schematic representations of the EB-PVD process in which the electron 





2.1.2 Fabrication of Thin-film Gold Electrodes 
In enzymatic biosensors, the WE is normally made of highly conductive and 
electrochemically stable materials, such as gold, platinum and carbon.50 Modifying these 
conventional electrodes with novel materials can improve their detecting performance.50 For 
example, platinum nanoparticle ensemble-on-graphene hybrid nanosheet was decorated onto 
the surface of a glassy carbon electrode and successfully increased its sensitivity towards 
H2O2 detection.51 Using gold nanoparticles and carbon nanotubes to modify electrode surfaces 
can help stabilize the enzyme molecules and facilitate electron transfer at the same time.52,53 
At the beginning of this project, we wanted to keep all procedures simple. As a result, 
pure gold was chosen to be the material of all electrodes and no additional modification of the 
electrode material was included. The lactate biosensor was designed to be a three-electrode 
system. The electrodes were all made of pure gold on a vinyl sheet by EB-PVD. The structure 
of the three-electrode system was designed with the following important parameters: the 
diameter of the WE was 2.7 mm; the width of the RE and CE was 0.7 mm; the space between 
the adjacent electrodes was 1 mm; the straight tail of the electrodes was 23 mm long. The 
overall image of this three-electrode system is shown in Figure 2.2. 
Figure 2.2 shows the electrode fabrication process. First, one piece of vinyl sheet was 
adhered to another to form a double layer structure. This double layer vinyl sheet was then cut 
by a cutting plotter using a medium cutting strength so that the outlines of the electrodes are 






formed only on the top layer (step a). In step b, those parts of the top layer inside the outlines 
were peeled off. Next, the double layer vinyl sheet with electrode patterns went through gold 
deposition by EB-PVD, during which 40 nm thick chrome and 200 nm thick gold were 
deposited in sequence (step c). The purpose of pre-depositing a layer of chrome is to enhance 
the adhesion between the substrate and the gold layer.54 At last, the rest of the top layer was 
peeled off and the gold electrodes were successfully fabricated on the vinyl sheet (step d). 
Since the electrodes-on-vinyl construct were thin and flexible, they are referred to as 
membrane electrodes, hereafter.  
Before further modification, the membrane electrodes were ultrasonic cleaned in 
isopropyl alcohol and liquid soap, each for 3 min, and rinsed by water. A 1 cm long optically 
clear adhesive membrane is attached to cover the straight stem portion of the electrodes as the 
insulating layer to define the active area of the electrodes. The active surface areas of CE, WE 
and RE are about 5.7, 5.7 and 2.4 mm2, respectively. The counter electrode is made to have a 
relatively large surface area to ensure the stability of current. 
2.2 Fabrication of Reference Electrode 
2.2.1 Ag/AgCl Reference Electrode 
The RE is an essential component in a biosensor that largely affects the accuracy and 
reliability of a sensor’s response. There are several common reference electrodes, including 
Ag/AgCl electrode, calomel electrode and hydrogen electrode. Among these electrodes, the 
Ag/AgCl electrode is most widely used in research because of its simple structure and ease of 
manufacture.39 The conventional macroscale Ag/AgCl electrode is typically a glass tube filled 
with a solution that has very high Cl- concentration, in which a Ag wire with AgCl coating is 
immersed. The glass tube is enclosed by a porous membrane.39 




(𝑎𝑞)                                           2.1 
From this reaction, it is clear that the activity of chlorine ion has an effect on the 
electrode potential. Applying Nernst equation to this reaction, the potential of the Ag/AgCl 
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) 𝑙𝑛𝑎𝐶𝑙−                                2.2 
where 𝐸0,𝐶𝑙
−|𝐴𝑔𝐶𝑙|𝐴𝑔 is the standard potential of a Ag/AgCl electrode (0.23 V ± 10 mV against 
standard hydrogen electrode) , R is gas constant, T is temperature, F is Faraday constant and 
𝑎𝐶𝑙− is the ion activity of chloride ion in solution.
55 The ion activity is treated to be equal to 
the ion concentration under some specific conditions. 
Ideally, the potential of one Ag/AgCl reference electrode should be constant. However, 
with the sustained use of the electrode, it might lose its ability to maintain the constant 
potential, resulting from the consumption of AgCl and the leakage of the internal filling 
solution.39 To extend the lifetime of a Ag/AgCl electrode, it must be immersed in a Cl- rich 
solution when it is not in use. 
Conventional Ag/AgCl reference electrodes are bulk and have internal filling solutions, 
limiting their application in WHMDs. Therefore, solid-state reference electrodes (SSREs) 
were developed to replace conventional electrodes so that they can be assembled into 
miniaturized sensors.56 Using SSREs also brings other benefits: the cost is greatly reduced; 
the mass production and maintenance of the electrode is simplified.57 However, while 
conventional reference electrodes can maintain a constant potential for a long time, the 
potential of SSREs is not constantly stable in the test solution. The miniaturization of the 
Ag/AgCl electrodes greatly reduces the amount of Ag and AgCl in the electrodes, shortening 
their lifetime.39 In some SSREs, Ag and AgCl were directly exposed to the test solution, 
leading to a greater variation of its potential.58,59 To optimize the SSREs, the Ag/AgCl layer 
could be covered by a membrane with abundant Cl- to play the role of a “solid filling 
solution”.39 For example, the agar gel saturated with Cl- was used to modify the SSRE and 
successfully improve the stability of electrode.60,61 
To fabricate the lactate biosensor of this project, which is supposed to be small-sized and 
flat, it is necessary to substitute the commercial reference electrode by a SSRE. The procedure 
of fabricating the SSRE will be introduced in the next section. 
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2.2.2 Fabrication of the Solid-state Ag/AgCl Electrode 
SSREs are commonly made by three methods: electrochemical deposition62, screen-
printing63 and sputter coating64. In this work, the solid-state Ag/AgCl electrode of the 
membrane electrodes was fabricated in two steps: 1. Depositing silver on the gold electrode 
by electrochemical deposition; 2. Oxidizing silver into silver chloride in 6% bleach. This 
method is cost effective and requires no specific equipment other than the electrochemical 
workstation which will be used to record the responses of the lactate biosensors to lactate 
concentrations later.  
The equipment that was used to perform the electrochemical deposition was the CHI-
650A electrochemical workstation from CHI Instrument, Inc. The RE and CE were purchased 
from the same company. AgNO3 powder and NH4OH solution were purchased from Sigma 
Aldrich.   
Figure 2.3 is a schematic representation of the setup for the electrochemical 
deposition of silver on one of the three membrane electrodes on a sensor. In this case, the RE 
of the membrane electrodes was used as the WE, a commercial Ag/AgCl electrode and a 
platinum wire were used as the RE and CE respectively. The electroplating solution was 3 mL 
of 0.1 M AgNO3 in 1 M NH4OH.  
To begin the silver deposition, a constant potential of -0.1 V was applied for 30 s to 





remove any microscopic gas bubbles on the electrode surface. Then, a constant potential of -
0.5 V was applied for 20 min to deposit silver and during this process, the current change was 
recorded by the electrochemical workstation. After the silver deposition, the membrane 
electrodes were immersed in 6% bleach for 30 s so that part of the Ag was oxidized to AgCl. 
The active component of the bleach is NaOCl. 
 Taken out from the bleach, the electrodes were immersed in Milli-Q water and 
jiggled so that loosely bound AgCl could be washed away. In the end, all the membrane 
electrodes were gently wiped to dry. 
During the whole process of the silver deposition, the WE and CE of the membrane 
electrodes stayed unchanged. When -0.1 V was applied, nothing varied on the surface of the 
RE of the membrane electrodes. As soon as -0.5 V was applied, a layer of ultra-thin silvery 
white coating appeared on the surface of the targeted electrode. Over time, this layer of silver 
grew thicker. Immediately after -0.5 V was applied, there was always a short period of time 
when the current decreased, which was due to the discharge of the electric double layer on the 
electrode.65 The current variation recorded by the electrochemical workstation during the 
silver deposition was not exactly the same every time, but the current of a successful silver 
deposition should roughly increase from 0.8 to 3 mA after the short initial dip. On one hand, 
if the current was too small, there would be insufficient silver, leading to the instability of the 
solid-state Ag/AgCl electrode; On the other hand, if the current was too large, the deposited 
layer would become less uniform and there would be some silver aggregates which could 
easily fall off from the electrode surface. Under the normal deposition rate, the silver layer 
grew perpendicular to the electrode surface. However, the over-rapid growth of silver could 
lead to the lateral spread of silver to the surface of the adjacent electrodes. As a result, it was 
necessary to keep the current of silver deposition within the mentioned range.  
Right after the electrode was placed in bleach, the silver layer turned black gray and 
little bubbles constantly arose from the Ag layer, indicating the formation of AgCl. Based on 
the production of gas in this process, the chemical mechanism of the silver reduction is 
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considered to be as follows: 
   2Ag(𝑠)  + 2NaOCl(𝑎𝑞) → 2AgCl(𝑠) + 2Na(𝑠) + 𝑂2(𝑔)                     2.3 
2.2.2 Characterization of the Solid-state Ag/AgCl Electrode 
To verify that the solid-state Ag/AgCl electrode functions properly as a RE, it was 
used to generate the CV grams of 0.5 mM K3Fe(CN)6 dissolved in 1 M KCl together with the 
WE and CE of the membrane electrodes. The CV grams were compared with the CV grams 
produced by using a commercial Ag/AgCl electrode. Three continuous CV scans were 
recorded using each (Figure 2.4). 
The two sets of CV grams possess similar features in the shape. They both have two 
distinct peaks and the potential difference between the two peaks in one cycle is constantly 
0.06 V. Based on this comparison, it is reasonable to say that this solid-state Ag/AgCl 
electrode is effective in terms of maintaining a constant potential for the WE.  
However, there is a constant potential shift of about 0.07 V between the CV grams 
generated by the two different reference electrodes. The potential values shown in Figure 2.4 
are the values of the actual potential applied on the WE subtracted by the offset potential of 
the reference electrode. Since the peaks of K3Fe(CN)6 have defined and positive potentials 
Figure 2.4. CV grams of 0.5 mM K3Fe(CN)6 in 1 M KCl. The potential of the working 
electrode is measured referring to a commercial Ag/AgCl electrode (black line) and the self-








versus absolute 0 V, and all Ag/AgCl electrodes have positive offset potentials, the reference 
electrode which leads to the smaller peak potential has the larger offset potential.  
Based on Equation 2.2, the offset potential difference between two Ag/AgCl 
electrodes can be expressed as:  






                                                  2.4 
If the electrode 1 is the solid-state Ag/AgCl electrode and the other is the commercial 
reference electrode, E1 － E2 will equal 0.07 V. According to Equation 2.4, the Cl- activity of 
the commercial electrode turns out to be about 15 times larger than that of the solid-state 
Ag/AgCl electrode. That is to say, the Cl- concentration in solution around the Ag/AgCl 
surface is much lower in the solid-state electrode than in the commercial electrode, which 
matches the reality. In the commercial electrode, the filling solution has 3 M Cl-, while the 
solid-state electrode is immersed in the electrolyte solution that has 1 M Cl-. 
2.3 Modification of Working Electrode 
2.3.1 Enzyme Immobilization Methods 
The sensitivity and stability of the lactate biosensors strongly depend on the activity of 
LOD on the electrode surface. As a result, LOD immobilization is a key step in the fabrication 
of the lactate biosensor. There are two purposes of the enzyme immobilization: 1. Keeping the 
enzymes close to the electrode surface instead of diffusing into the test solution; 2. Providing 
a friendly environment to the enzymes so that they will not be denatured, and their active sites 
can function properly. 
Many enzyme immobilization methods have been reported and they can be classified in 
five categories (Figure 2.5).66 Depending on the type of interaction between enzymes and the 
electrode, they can be further identified as chemical or physical immobilization. Covalent and 
cross-linking are chemical immobilization methods. For covalent, enzymes form covalent 
bonds with the electrode whose surface is coated with polymers through carboxylic and 
amino groups. For cross-linking, enzymes are cross-linked by crosslinkers with each other or 
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with other inert proteins.66  
Other three methods are physical immobilizations. Enzyme entrapment means that 
enzymes are encapsulated into a three-dimensional gel or polymer network. Adsorption 
means that enzymes interact with the substrate through weak forces, such as van der Waal's 
forces and electrostatic interactions. Affinity relies on the affinity of enzymes towards a 
modified electrode resulted from some specific protein sequence, which is similar to the 
antibody-antigen interaction.66 
Using chemical immobilization, enzymes are fixed in a stable way but can lose a lot of 
their activities. On the other hand, physical immobilization may have the problem of enzyme 
leaching but retains enzyme activity to the greatest extend. 
Although most loss of enzyme activity is caused by their denaturation, the random 
orientation of enzymes on the electrode surface is another significant reason. Those enzymes 
whose active site are not exposed to the test solution might have difficulty interacting with 
their substrates.66 Specifically designed covalent and affinity immobilization methods are able 
to immobilize enzymes in an ordered and oriented way, which further boost the general 
activity of enzymes.67,68 
Nanomaterials such as carbon nanotubes and a variety of nanoparticles are popular 





materials to immobilize enzymes. As mentioned before, carbon nanotubes are highly 
conductive and facilitate the electron transfer between the enzymes and the electrode; 
meanwhile, they can provide mechanical and structural support to the enzymes.69 
Nanoparticles have high conductivity as well. They provide a larger surface area for enzymes 
than the macro electrode surface dose, reducing the denaturation of enzymes.67,70 
2.3.2 Immobilization of LOD 
In this work, LOD was immobilized together with bovine serum album (BSA) cross-
linked with glutaraldehyde (GA). GA is considered as the most widely used and the most 
effective cross-linker of proteins.71 It can react with several functional groups of amino 
acids.72 In enzyme immobilization, GA primarily forms covalent links with the lysine groups 
of enzymes.73,74 As a result, when inert and lysine-rich proteins, such as BSA, are co-
immobilized with enzymes, the process of cross-linking becomes more effective.75 It is 
proven by previous work that when enzymes are co-immobilized with BSA, the loss of their 
activity could be reduced, and the response of biosensors could be more accurate.75–77   
Figure 2.6A clearly shows the binding between GA and the enzyme, in which the AL 
Figure 2.6. Schematic presentations of the enzyme crosslinking using GA in the (A) absence 




stands for alginate lyase and could represent all enzymes.78 GA forms C=N bonds with the ϵ-
amino groups of the enzymes.72,78 If these ϵ-amino groups exist at the active site, this enzyme 
is deactivated. When a large amount of BSA is present in this matrix, GA molecules are more 
likely to react with BSA as presented in Figure 2.6B.78 Therefore, modifications to the active 
sites of the enzymes will be reduced. 
To immobilize LOD on the WE of the membrane electrodes, LOD lyophilized powder 
was purchased from AG Scientific. 25% GA solution and BSA lyophilized powder were 
purchased from Sigma Aldrich. 10× PBS was purchased from EMD.  
10× PBS was diluted to 1× PBS with Milli-Q water. 20 mg/mL LOD solution and 150 
mg/mL BSA solution were prepared by dissolving their powder in 1× PBS. 25% GA solution 
was diluted to 10% using Milli-Q water. Both the LOD and BSA solution was light yellow 
and the GA solution was transparent.  
The enzyme immobilizing matrix was composed of 7.5 μL BSA, 7.5 μL GA and 10 μL 
LOD solutions. The matrix was freshly prepared by mixing the three solutions every time 
before use. During the mixing of the solutions, bubbles occurred easily and were hard to 
remove. As a result, after mixing, only 13 μL of the mixture, in which no bubbles exist, was 
dropped onto the surface of the WE. The electrode was then left in the fume hood and 
exposed to the air for 40 min. Afterwards, the liquid mixture turned from a hemisphere into a 
flatter and gel-like membrane that covered the whole WE. The color of the mixture also 
turned light brown from light yellow.  
After the enzyme immobilization, the electrodes were immediately used for the 
following tests instead of being stored by any means. Before being used, the electrodes were 
washed by a gentle flow of Milli-Q water to get rid of the unbound substance and dabbed to 
dry.  
After the preparation of the solid-state Ag/AgCl electrode and the enzyme electrode, the 
membrane sensors were ready to be used for lactate detection in liquid samples.   
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Chapter 3. Electrochemical Detection of Lactate 
3.1 Cyclic Voltammetry and Differential Pulsed Voltammetry 
Two electrochemical techniques, CV and differential pulse voltammetry (DPV), were 
used for recording the electrochemical responses of the membrane sensors in this work. These 
two techniques were performed by the CHI-650A electrochemical workstation (CHI 
Instrument, Inc.). The principle of CV and DPV are introduced in this section. 
CV is a measurement of the current value at the WE when the potential applied on it 
cycles between two set values with a certain scan rate as shown in Figure 3.1a.79 CV gives an 
insight into redox reactions. Figure 3.1b is an example of CV gram which is the CV gram of 6 
mM K3Fe(CN)6 in 0.1 M KNO3 solution.80 During the forward scan, from 0.8 V to -0.2 V, 
when the potential becomes negative enough, Fe(CN)63- gets reduced into Fe(CN)64- and 
results into a cathodic current. In the reverse scan, from -0.2 V to 0.8 V, when the potential is 
positive enough, Fe(CN)64- gets oxidized back to Fe(CN)63- and an anodic current is formed.80 
Such an electrochemical reaction is defined to be reversible and produces the most typical CV 
gram with two defined peaks. Meanwhile, other electrochemical reactions could be quasi-
reversible and irreversible, generating CV grams like plot b and c in Figure 3.1c, 
Figure 3.1. (a) The potential-time profile of one cycle in CV.79 (b) The cyclic voltammogram 




 in 1 M KNO
3
 (SCE: saturated calomel electrode, scan rate: 50 mV/s).80 






respectively.79 In the CV gram of an irreversible reaction, only one peak could be observed.79 
There are established equations that express the magnitude of Ip for the different types of 
CV grams. For example, when a macroelectrode is used, the Ip of a reversible and irreversible 
CV could be defined by Equation 3.1 and 3.2:  
Reversible:𝐼𝑝
𝑅𝑒𝑣 = ±0.446𝑛𝐹𝐴𝐶(𝑛𝐹𝐷ʋ/𝑅𝑇)1/2                             3.1 
Irreversible: 𝐼𝑝
𝐼𝑟𝑟𝑒𝑣 = ±0.496(𝛼𝑛′)1/2𝑛𝐹𝐴𝐶(𝐹𝐷ʋ/𝑅𝑇)1/2                   3.2 
where F and R are Faraday‘s constant and the gas constant, respectively; ʋ is the scan rate; T 
is the temperature; A is the area of the electrode surface; n and n’ are the numbers of electrons 
transferred per mole during the whole process and before the rate determining step, 
respectively; α is the transfer coefficient; D is the diffusion constant of the reactant; C is the 
concentration of the reactant.79  As a result, by keeping all the other parameters the same, one 
could get a Ip from CV that is solely determined by the concentration of the reactant.   
Different from CV, DPV has a potential profile which is a combination of staircase 
and pulse as shown in Figure 3.2a.79 By applying potential in this way, the capacitative 
current caused by the double-layer charging at the electrode surface could be eliminated. As a 
result, the current detected by DPV is pure Faradic current. Figure 3.2b is a typical DPV 
gram.79 The current presented in a DPV gram is the difference between two values, I2 and I1, 
which is recorded at the point 2 and 1 as labelled in Figure 10a, respectively. DPV is normally 
used instead of CV to enhance signal or distinguish two close peaks. The same as CV, the Ip 





of DPV is proportional to the concentration of the reactant when all the other conditions 
remain unchanged.79 
3.2 Cyclic Voltammogram of Lactate 
To get an overall understanding of the electrochemical behavior of lactate, the CV gram 
of lactate was firstly generated by a standard three-electrode system within a large potential 
range (between 0.65 V and -0.5 V). The standard three-electrode system was composed of 
commercial electrodes: a 2 mm-diameter gold disk electrode as the WE, a platinum wire as 
the CE and a commercial Ag/AgCl electrode as the RE. LOD was immobilized on the WE by 
the same enzyme immobilization method introduced in Section 2.3.2 while 15 μL of the 
mixture was dropped onto the WE surface. All electrodes were fixed by a Teflon cap so that 
the distances between three electrodes and the active surface area of the CE were consistently 
the same.  
Before the electrodes were used to detect lactate, they were activated by several CV 
scans in 1× PBS. Seven beakers were prepared, each containing 4 mL 1× PBS with various 
concentrations of lactate as listed in Figure 3.3. The electrodes were placed into one beaker 
and one cycle of CV was performed. Before every CV scan, there was a 10 s quiet time. 





When the test in one beaker was completed, the electrodes were taken out, rinsed by Milli-Q 
water, dabbed to dry and immediately placed into the next beaker for the next CV scan. The 
lactate solutions were detected by the electrodes from the lower to higher concentration.  
The standard CV grams of different lactate concentrations that were generated by the 
standard electrode system are shown in Figure 3.3. In each CV gram, there are two peaks. 
During the positive scan, from -0.5 V to 0.65 V, there is a small peak between 0.2 and 0.4 V, 
but it declines as the lactate concentration increases. It is not clear that where this peak 
originates from. During the reverse scan, from 0.65 V to -0.5 V, there is an evident and 
defined peak at -0.3 V. This peak grows when the lactate concentration in the solution 
increases. According to the definition of the peaks in CV grams introduced in Section 3.1, the 
second peak is recognized as the cathodic peak that represents the reduction of H2O2.  
There should be an oxidation peak of H2O2, however, it is not observed in all the CV 
grams. Since the lactate biosensor is required to work within a low potential range (whether 
negative and positive) and it turned out that the reduction peak appeared at a lower potential 
than the oxidation peak, no attempt was made to find the oxidation peak.     
Based on this set of standard CV spectra of lactate, the potential range of interest of the 
following electrochemical tests was determined to be smaller than 0 V so that the reduction 
peak of H2O2 would be detected to represent the concentration of lactate.  
3.3 Lactate Detection by the Membrane Sensors 
After the successful detection of lactate in PBS by the standard electrode system, the 
responses of the membrane sensors to lactate were tested by CV using a similar procedure. As 
introduced in Chapter 2, the membrane sensors had a LOD-immobilized WE, a gold CE and a 
solid-state Ag/AgCl electrode.  
In total, three membrane sensors were tested. All membrane sensors were activated in 1× 
PBS by several CV scans. In each test, there were seven beakers that each contained 4 mL 1× 
PBS with the lactate concentration of 1, 3, 5, 7, 10, 20 and 30 mM. One membrane sensor 
was placed into the beakers in sequence, from the lower to higher lactate concentration, and 
26 
 
one CV gram was recorded in each beaker. Before every CV scan, there was a 10 s quiet time. 
Every time that the membrane sensor was taken out from one beaker, it was rinsed by Milli-Q 
water and dabbed to dry.    
Figure 3.4a is a set of the CV grams produced by one of the membrane sensors. The 
potential range is between 0 and -0.8 V. The scan rate is 0.05 V/s, which is five times of the 
scan rate of the CV in section 3.2. The reason why the potential scan was accelerated was that 
under a very slow scan rate, like 0.01 V/s, the membrane sensor produced unstable signal 
instead of a smooth curve, which might have resulted from the solid-state Ag/AgCl electrode. 
This generated reference electrode might not be able to control the potential as precisely as 
the commercial reference electrode can do.  
In every CV gram in Figure 3.4a, there is an evident peak. Different from the position of 
the H2O2 peak generated by the standard electrode system, the H2O2 peak in Figure 3.4a is 
located around -0.65. The huge shift of H2O2 peak from -0.3 V (in Figure 3.3) to -0.65 V can 
be partly explained by the replacement of the commercial Ag/AgCl electrode by the solid-
state Ag/AgCl electrode. The Cl- concentration of 1× PBS is 0.14 M, which is much smaller 
than that of the filling solution (3 M) in the commercial Ag/AgCl electrode. If we consider the 
activity of Cl- the same as its concentration and the 
𝑎𝐶𝑙−2
𝑎𝐶𝑙−1
 in equation 2.5 equals to 3 M 
divided by 0.14 M which is 21.4, we will get the potential difference between two reference 
Figure 3.4. (a) The CV grams of a membrane sensor in 4 mL PBS with different lactate 
concentrations (1-30 mM). (scan rate: 0.05 V/s) (b) The calibration curve of the membrane 
sensors in PBS which shows the change of Ip over lactate concentration on a semi-logarithmic 





electrodes as 0.078 V, which is much smaller than the actual potential shift. The use of a gold 
CE, instead of a platinum wire, could also contribute to the shift of peak position.  
The absolute values of Ip generated by different membrane sensors in the same lactate 
concentration varied from one sensor to another. However, after baseline correction, i.e., 
subtracting the Ip of 1 mM from each Ip, the calibration curves of three membrane sensors 
could be presented in one plot. The inset of Figure 3.4b is the original calibration curve of the 
membrane sensors. It can be seen that Ip increases almost linearly with the lactate 
concentration in the range of 1 to 10 mM. However, after 10 mM, the slope of the change of 
Ip becomes smaller, which means the signal starts to saturate, as expected.  
From every membrane sensor, KM and Vmax, which are the essential parameters in 
Michaelis–Menten equation, can be calculated out to characterize the LOD immobilization on 
the electrode. The mean values of these two parameters is KM = 8.18 (± 2.30) mM and Vmax = 
6.55 (± 1.17) μA. There are large deviations among the three membrane sensors, indicating 
that each enzyme electrode varies from each other. As stated before, after LOD, BSA and GA 
are mixed, only 13 μL of the mixture is used. If LOD is not uniformly distributed, the total 
amount of LOD on the WE will be inconsistent for the sensors. After being crosslinked, the 
amount of LOD whose active site has been modified varies every time, altering the amount of 
active LOD. A larger amount of active LOD is likely to result into a larger current. The 
immobilization not only chemically modifies LOD but also fixes its orientation. Therefore, 
the affinity between lactate and LOD, represented by KM, is different in each enzyme matrix. 
During the 40-min crosslinking process, the enzyme matrix is also dried by air flow. Its 
thickness can be affected by its surface area as well as the flow rate and humidity of the air. 
Since the total amount of BSA and LOD varies, the density of these two is even more 
inconsistent in the enzyme matrixes considering their varying thickness. The protein density 
influences the mass transport of lactate and H2O2 inside the enzyme matrix, thus likely to 
bring changes to both KM and Vmax.  
Since we are interested in the abnormal high lactate level in the human body, a larger 
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dynamic response range is desirable. The calibration curve in Figure 3.4b is established on the 
logarithmic values of lactate concentrations. In this way, the dynamic range of our membrane 
sensors is 4 to 30 mM. The detection limit (30 mM) is larger than the highest physiological 
lactate level stated in Section 1.3 (18 mM).  
Two essential parameters, limit of detection (LoD) and sensitivity, can be derived from 
the calibration curves. LoD is the minimal detectable concentration and is defined as 
3.3*ơ1/s1, in which ơ1 and s1 are the standard deviation of response and the slope of the 
original calibration curve, respectively.81 Based on the linear range of the original calibration 
curve, the LoD of the membrane sensors is calculated to be 1.54 mM. Sensitivity (ΔCmin) is 
defined as the minimal difference between two distinguishable concentrations C1 and C2 
(C1<C2). It is calculated following this equation: ΔCmin = C2–C1 = (C2/C1–1)*C1 = 
{10^(3.3*ơ2/s2)–1}*C1. ơ2 and s2 are the standard deviation of response and the slope of the 
semi-log calibration curve, respectively. The ΔCmin of the membrane sensors is determined to 
be 0.78C1 mM in the linear range of the semi-log calibration curve. That is to say, for the 




Chapter 4. Transdermal Detection of Lactate 
4.1 Distribution of Body Fluid in Skin 
Most biosensors require liquid samples. For biosensors in WHMDs, various body fluids 
can be collected as samples to monitor various health indicators, including interstitial fluid 
(ISF), sweat, tear and saliva.82–85 In terms of lactate detection, it was reported that capillary 
blood lactate levels correlate well with systemic blood lactate levels in both steady and 
varying states.86 In ISF, the lactate level is higher than that in blood at rest and it follows the 
blood level with a 30-min delay.87 As a result, to monitor lactate level in the human body, ISF 
and capillary blood are reliable substitutes of systemic blood.  
The distribution of ISF and capillary blood in the human skin is shown in Figure 4.1. 
Skin is the largest organ of human body.88 The epidermis is the outermost layer of skin with a 
thickness varying from 50 to 150 μm. It is a protective layer of the human body without blood 
vessels.89 Beneath the epidermis is the dermis which has a large amount of ISF.90 ISF 
constitutes about 45% of skin volume and contains many analytes of interest since it 
transports materials and molecules between cells and blood capillaries, cells and cells.89 At a 
Figure 4.1. A schematic representation that shows the structure of the three layers in the 
human skin, including the epidermis, dermis and hypodermis.89 
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depth of 300 to 600 μm from the skin surface, there is a superficial plexus, composed of small 
capillary blood vessels.89 Capillary blood is a good substitute for systemic blood in terms of 
health inspection. It originates from systemic blood, having the same constituents at similar 
concentrations.89   
4.2 Extraction of ISF and Capillary Blood 
The transdermal extraction of ISF and capillary blood is minimally invasive to human 
body compared to the collection of systemic blood, making WHMDs more suitable for daily 
use. For a WHMD, although a high-quality sensor is essential, the way of collecting body 
fluids can also strongly influence its acceptability to the users. There are some extraction 
methods that can be used at home by untrained people. The most direct method is using a 
lancet to pierce skin. Several more comfortable ways involve the use of laser ablation, ultra 
sound and reverse iontophoresis.91 Laser ablation and ultra sound can open pores in the 
epidermis so that some ISF is released. Reverse iontophoresis works by building up an ion 
flow across the skin so that analytes can be extracted out of the skin with this ion flow.91 
With the development of fabrication technology on the micrometer level, various types 
of microneedle arrays have been produced and used in transdermal applications, including 
drug delivery and body fluid extraction. Since Henry et al. first applied silicon microneedles 
to deliver a model drug through the epidermis in 1998, microneedle arrays have experienced 
extensive usage in transdermal drug delivery.93,94 In this field, both solid and hollow 
Table 4.1. Requirements for hollow microneedles which are used to extract body fluids.92 
 Hollow microneedle array 
Function Extract capillary blood Extract interstitial fluid 
Penetration depth 400–900 µm 50–150 µm 
Lumen diameter At least 50 µm At least 10 µm 
Material Higher strength Relatively lower strength 
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microneedle can be used.93 While to extract body fluid out of the human body, hollow 
microneedles are required. Some basic requirements for hollow microneedles are listed in 
Table 1. 
As mentioned previously, Henry et al.’s microneedle arrays were made of silicon.86 
Silicon has been verified to have short-term biocompatibility.95 However, the long-term 
influence of silicon to the human body is not clearly defined. Meanwhile, silicon is brittle and 
expensive, which further prompted scientists to find other materials to make microneedles.96 
For example, there have been microneedles made of polymers and sugars97–100. Such materials 
are better than silicon in terms of their degradability in the human body.96  
Although microneedles can have various dimensions all of them are expected to be 
minimally invasive to the human body and cause very slight pain. This was determined by 
one research where microneedle arrays with 5 or 50 microneedles that have different lengths 
(480 to 1450 μm), widths (160 to 465 μm) and thicknesses (30 to 100 μm) were applied on 
the volar forearms of ten healthy human subjects. Comparing to a hypodermic needle, these 
microneedle arrays caused 60 to 95% less pain to the subjects.101  
In conclusion, transdermal extraction of body fluids can be accomplished by 
microneedles. In this project, two kinds of transdermal microneedle patches that were 
manufactured by 3M Canada were used. These transdermal patches were originally made for 
transdermal drug delivery so that their biocompatibility was guaranteed. Referred to as long 
needles and short needles, they are 1500 and 1000 μm long, respectively. Each microneedle 
patch has 12 microneedles lined in a circular shape and the lumen diameter of all 
microneedles is 80 μm. All microneedle patches are made of liquid-crystal polymer.  
4.3 On-skin Operation of the Membrane Sensor 
 The ultimate goal of this project is to fabricate a device that can quantify lactate level 
transdermally. That is to say, this device should be able to collect and detect the body fluid 
simultaneously. For this purpose, we attached the lactate membrane sensor as described in 
Chapter 3 to the transdermal microneedle patch from 3M Canada.  
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Figure 4.2 is an illustration of the general concept of lactate detection conducted 
using our device. As introduced before, to collect capillary blood, the penetration depth of the 
microneedles should be 400 to 900 μm.92 Our microneedles are 1500 and 1000 μm long so 
that they are expected to be able to reach the blood capillaries when they are inserted into the 
human skin. As a result, the body fluid sample that is extracted out is likely to be a mixture of 
capillary blood and ISF. On top of the transdermal patch, there is a chamber to accommodate 
a small volume of the extracted body fluid. A membrane sensor is attached to the transdermal 
patch and situated inside this chamber. When enough body fluid is collected (>100 μL), the 
sensing electrodes will be immersed in the fluid and the enzymes on the WE will start to 
oxidize lactate. The tail of the membrane sensor extends out of the chamber so that it can be 
electrically wired to the electrochemical workstation. As soon as a proper potential is applied 
to the WE, H2O2 will be reduced and current will be produced. The current will be detected 
and recorded by the electrochemical workstation. This electrical signal will be sent to and 
analyzed by another device. This device will translate the electrical signal into the lactate 
concentration based on the calibration curve of the membrane sensor.  
For proof of concept, a sensor-enclosing device (SED) was fabricated, using which 





sample collection and detection of lactate were demonstrated. The procedure of fabricating 
the SED is described in the next section.  
4.4 Fabrication of the Sensor-enclosing Device 
Poly(methyl methacrylate) (PMMA) and Polydimethylsiloxane (PDMS) are the main 
materials that constitute the SED. PMMA plates are cut into desired shapes using a laser 
cutter. PDMS is made by mixing the base and curing agent with a weight ratio of 10:1 and 
curing the mixture at 80 °C overnight.  
Figure 4.3a is a picture of the whole SED. This device can be disassembled into three 
layers. The upper and bottom layers are made of PMMA. The middle layer is made of PDMS. 
Figure 4.3b shows the chamber and the small tube connecting to the chamber through the 
PMMA casing. Each PMMA casing consists of three pieces of PMMA bonded together 
(Figure 4.3c). The first and second pieces of PMMA have a big square hole and a small 
circular hole in the middle, respectively. After being glued together, these two pieces of 
PMMA form the chamber. The last piece of PMMA is made for the tube fixation. After the 
Figure 4.3. A picture of (a) the SED and (b) the PMMA layer. (c) A schematic drawing of 
three PMMA pieces that constitute the PMMA casing. A picture of (d) the tube fixation by 
PDMS and (e) the PDMS layer holding the transdermal patch. (f) A picture of the membrane 





tube is inserted into the middle hole, liquid PDMS is poured into the gap between the tube 
and the small PMMA piece (Figure 4.3d). When the PDMS gets solidified, liquid leakage 
between the tube and the PMMA is prevented.  
Figure 4.3e displays the middle PDMS layer holding a transdermal patch. The hole of the 
PDMS layer is made to be smaller than the transdermal patch so that when the transdermal 
patch is placed into the PDMS layer, it is held very tight. There is no gap between the 
transdermal patch and the PDMS so that the only path for liquid to transfer between the top 
and bottom is through the microneedles. The membrane sensor is glued onto the back of the 
transdermal patch by epoxy. When the membrane sensor is placed in the device, it can be 
connected to the external circuit as shown in Figure 4.3f.  
When the membrane sensor and the transdermal patch are pressed onto the human skin, 
body fluid will be extracted out through the microneedles and immerse the sensor. This 
process can be mimicked by pumping liquid into the SED using a syringe through the bottom 
tube. 
4.5 Mass Transport through the Microneedles 
The microneedles have an extremely small radius which means they have the potential to 
suck liquid up by capillary force. However, these microneedles have hydrophobic surface that 
will hinder the flow of liquid. As a result, when a transdermal patch pierces the human skin, 
body fluids is not likely to be automatically extracted out. To facilitate the extraction, a 
vacuum or low-pressure environment is probably required outside the skin to create a pressure 
difference across the transdermal patch.  
To provide some hints about how much the pressure difference across the transdermal 
patch should be to reach a desired flow rate of liquid extraction, a mass transport experiment 
was performed. 
4.5.1 Materials and Methods 
In each mass transport experiment, one transdermal patch was placed inside the SED 
with its needle tips facing down. The experimental setup is shown in Figure 4.4a. The bottom 
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tube of the device is connected to a burette. The burette contains a certain amount of liquid 
and is used to create the pressure that leads to the liquid transport from bottom to up through 
the microneedles in the device. The specific value of the pressure is calculated according to 
the equation below: 
∆P =  ρgh                                                                4.1 
where ρ is the density of the liquid used, g is the gravitational constant and h is the height 
difference between the liquid surface in the burette and the end of the upper tube. 
Two types of liquid were tested, water and a glycerol solution. The glycerol solution was 
a mixture of 55 % water and 45 % glycerol (by weight). This mixture had a dynamic viscosity 
of 4.4 cP at room temperature which is similar to the dynamic viscosity of human whole 
blood at 37 ºC.102 Before each experiment, the liquid was filled up to the end of the upper tube 
of the device. Each mass transport experiment lasted for 3 min during which the valve of the 
burette was kept open and extra water or glycerol solution was constantly added into the 
burette to maintain a constant liquid level. After 3 min, the mass of the liquid extruded from 
the upper tube, collected in the small beaker, was weighed and converted into its volume. For 
calculation, the water density was treated as 1 g/cm3 and the density of the glycerol solution 
was 1.1126 g/cm3. The average flow rate of the mass transport was calculated by dividing the 
volume of transported liquid by 180s.  
4.5.2 Results and Discussion 
The results of the mass transport experiment are presented in Figure 4.4b. As indicated 
by the small error bars in Figure 4.4b, by maintaining a constant height of liquid in the 
burette, a cross-patch pressure (up to 3000 Pa) can be stabilized at a certain value very 
accurately during the 3-min test. The transport rates of water and glycerol solution increases 
linearly with increasing pressure. This linear relation also indicates that the SED is sealed 
well: there is no air or liquid leakage. Comparing among four tests, the flow rate profiles 
possess four different slopes. Under the same pressure, both water and glycerol solution have 
a higher flow rate when they are transported through short needles. Water, the liquid with 
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lower viscosity, always has a higher transport rate than the glycerol solution when the driving 
force is the same. 
To get an insight into these results, the Hagen-Poiseuille equation should be employed, 
which can be used to calculate the volumetric flow rate of Newtonian fluid that flow 





                                                       4.2 
where ΔP is the pressure drop between the ends of the tube, μ is the dynamic viscosity of the 
liquid and L is the length of the tube.103 When ΔP and μ is constant, Q is inversely 
proportional to L, meaning that shorter needles can lead to a faster transport rate. Under a 
certain ΔP, when the needle length L is constant, Q is inversely proportional to μ. The liquid 
with a lower viscosity will have a higher flow rate. Our results are consistent with the Hagen-
Poiseuille law. 
Based on the two plots about the transport rates of the glycerol solution in Figure 4.4b, 
one could estimate the pressure difference across the microneedles that is required to extract a 
Figure 4.4. (a) A picture of the setup for the experiment of liquid transport through the SED. 
(b) The flow rates of water and glycerol solutions through short and long microneedles driven 





desired volume of body fluid within a desired duration of time. For example, to fill the 
sample-collection chamber of the SED (volume: ~300 μL) with blood in 15 s, when using the 
transdermal patches with short and long needles, the pressure in the chamber should be 2.3 
and 3.2 kPa smaller than the pressure inside the human skin, respectively. In fact, the capillary 
pressure of an adult is normally 2.2-2.4 kPa higher than the atmospheric pressure.104 
Therefore, even the collection chamber is not manually depressurized, body fluid should be 
able to be extracted out automatically and quickly through both types of microneedles. 
4.6 Lactate Detection in the Device 
After that the sealing of the SED was confirmed to be reliable, and the mass transport 
experiments were successfully done, the simultaneous sample collection and detection using 
the membrane sensors were investigated. 
4.6.1 Materials and Methods 
First of all, a membrane sensor was adhered to the back of the transdermal patch by 
epoxy and they were assembled inside the SED. Then, the sensor was electrically wired to the 
electrochemical workstation. A picture of this setup is presented in Figure 4.3f.  
Before lactate detection, 2 mL of 1× PBS was pumped into the device by a syringe and 
several cycles of DPV was performed to activate the electrodes. During the DPV scans, both 
the bottom and upper tubes were closed to keep the liquid inside the device. After the scans 
were completed, the liquid was drained out of the device from the bottom tube. For lactate 
detection, about 1.5 mL testing sample was pumped into the device each time. The upper 
chamber was bound to be filled with the testing sample. PBS with increasing concentrations 
of lactate was pumped into the device and drained out in sequence. One DPV gram acquired 
by the membrane sensor was generated for each concentration of lactate. Some important 
parameters of DPV used were as follows: the potential decreased from -0.1 V to -0.8 V; the 
pulse width, sample width, pulse period were 0.1 s, 0.01 s and 0.8 s, respectively.  
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4.6.2 Results and Discussion 
All the results of lactate detection by the membrane sensor inside the SED are presented 
in Figure 4.5. Figure 4.5a shows the DPV grams of one membrane sensor for various lactate 
concentrations in PBS. The DPV spectra in Figure 4.5a are consistent with the CV signals 
collected from the membrane sensors that detected lactate in beakers. There is a defined peak 
at about -0.6 V which represents the reduction of H2O2. Although the peak position varies a 
little compared to that in the CV grams, this peak grows with the increasing lactate 
concentration. Again, to plot one calibration curve for all three membrane sensors, baseline 
correction was done by subtracting the Ip of 1 mM lactate from other Ip. In Figure 4.5b, the 
calibration curve is plotted in semi-log scale. As can be seen from the calibration curve, the 
membrane sensors that are placed inside the SED retained the dynamic response range from 4 
to 30 mM. This result confirms that the membrane sensor can be assembled into a transdermal 
Figure 4.5. (a) The DPV grams of one membrane sensor immersed in PBS with different 
lactate concentrations in the SED. (b) The calibration curve of the membrane sensors in PBS 
in the device which shows the change of Ip over lactate concentration on a semi-logarithmic 
scale. (c) The DPV grams of one membrane sensor immersed in PBS with low lactate 
concentrations in the SED. (d) The relationship between the Ip of both oxygen and lactate 




device and reliably detect lactate in a small amount of sample.  
Using DPV, it is possible to inquire into the responses of the membrane sensors to lactate 
concentrations lower than 1 mM, where an additional peak is observed close to the H2O2 
peak. As can be seen from Figure 4.5c, there is an extra peak at -0.4 V when very low lactate 
concentrations are detected. This peak drops evidently when the lactate concentration 
increases. It is identified as the reduction peak of O2. According to the principle of lactate 
detection (Equation 1.1 & 1.3), O2 is consumed to produce H2O2 and the reduction of H2O2 
generates no O2. Thus, O2 level decreases as the lactate concentration increases. To further 
verify, the DPV grams of PBS were recorded before and after nitrogen was bubbled through 
the solution. The peak at -0.4 V declined sharply after nitrogen bubbling to reduce oxygen.  
Figure 4.5d presents how the Ip of the O2 and H2O2 peaks vary with the lactate 
concentration. Based on the specific values of the slopes of the two plots, we can see that the 
decline of O2 signal is 3 times faster than the increase of H2O2 signal. According to Equation 
1.1 and 1.3, O2 and H2O2 are consumed and produced at the same rate since their 
stoichiometric ratio is 1. On the WE, the reduction of H2O2 and O2 yields 2 and 4 electrons, 
respectively. To sum up, the decline of O2 peak should be 2 times faster than the increase of 
H2O2 peak in theory. In the experiments, the H2O2 peak grows slower than expected. The 
reason is that O2 reduction can go through either a 4-electron direct pathway, or a succession 
of two bi-electronic steps which involves H2O2 as an intermediate species. In another word, 
H2O2 is generated not only by lactate oxidation but also by O2 reduction. This also explains 
why there is a H2O2 peak when no lactate presents in the solution. When there is lactate, its 
oxidation contributes to a larger H2O2-reduction Ip. However, since O2 is consumed the H2O2 
current caused by O2 reduction gets smaller. To compensate the loss of current, the H2O2 peak 
is unable to increase at the expected rate.  
4.7 Stability of the Membrane Sensor 
The results of the previous section also demonstrated the short-term stability of the 
membrane sensor in the device. To be more comprehensive, the relative long-term stability of 
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the membrane sensor in a few hours, was investigated.  
Before the stability test, 30 mL of 7 mM lactate solution was prepared in 1× PBS. A 
membrane sensor was assembled into the SED and activated by several CV scans in 1× PBS. 
The pure PBS was then drained out from the bottom tube, 2 mL of 7 mM lactate solution was 
pumped into the device using s syringe and the tubes of the device were closed. After the 
electrodes were immersed in the solution and a quiet time of 10 s, one cycle of CV was 
applied. The lactate solution was kept inside the device until 5 min later so that the electrodes 
were constantly immersed in liquid. After 5 min, the old solution was drained out, 2 mL of 
fresh 7 mM lactate solution was pumped into the device and CV was scanned after the quiet 
time. Then, this procedure was repeated 10 times, at 15 min, 30 min, 1 h, 2 h, 3 h, 4 h, 5 h, 6 
h, 7 h, and 8 h after the first CV test. During the eight hours of the stability test, the membrane 
sensor was constantly immersed in the lactate solution.  
The CV grams of the membrane sensor during the stability test are shown in Figure 4.6. 
The shape of the CV gram remained almost unchanged during the first five hours although 
there were some slight variations in terms of the value and position of Ip. After 5 h, the shape 
of the CV grams clearly altered, and the peak height started to significantly increase. 
Although the CV gram ends at -0.8 V, it appeared that the H2O2 peak kept shifting towards the 
more negative potential side. 
To conclude, the membrane sensor can remain relatively stable inside the SED for 5 
Figure 4.6. The CV grams of one membrane sensor after being constantly immersed in PBS 





hours. The fading of the solid-state Ag/AgCl electrode likely caused most of the sensor 
instability. Over time, the enzyme immobilizing matrix swelled a bit. However, enzyme was 
successfully retained on the WE for 8 hours since H2O2 peak was always observed. If the 
membrane sensor is immersed in PBS longer, the enzyme matrix can detach from the WE and 
even dissolve into the solution.  
4.8 Lactate Detection in Real Samples 
After we confirmed that our lactate membrane sensor was sensitive to lactate 
concentrations in 1× PBS, we wanted to test it in real body fluid samples. Two types of real 
samples, human plasma and whole blood, were purchased from BioIVT. Human plasma was 
frozen at -20 °C, thawed at 37 °C in a water bath, and used at room temperature. Human 
whole blood was stored at 4 °C, used at room temperature, and disposed after two weeks of 
storage.   
4.8.1 Lactate Detection in Human Plasma 
 The lactate concentration in pure plasma was unknown. The test samples were prepared 
according to the various volume ratios between the pure plasma and highly concentrated 
lactate solution listed in the table in Appendix A. The lactate detection in human plasma was 
performed in the SED. All procedures, including the electrode activation and the sample 
detections were the same as stated in Section 4.6.1. In terms of DPV, the same settings were 
used.  
Figure 4.7. (a) The DPV grams of one membrane sensor immersed in human blood plasma 
with various lactate concentrations in the SED. (b) The calibration curve of the membrane 





The results of lactate detection in human plasma are presented in Figure 4.7. It is clear 
that in Figure 4.7a, the peak at about -0.6 V elevates as the lactate concentration goes up. To 
plot the calibration curve of these membrane sensors, the Ip of pure plasma are subtracted 
from the signals as background correction. In a semi-log scale, as the spiked lactate 
concentration rises from 5 to 30 mM, Ip increases linearly. Considering the normal lactate 
level in human body stated before (0.5-2 mM), the dynamic response range of the membrane 
sensors in plasma is 5.5/7 to 30.5/32 mM, which is similar to the dynamic detection range of 
the membrane sensors in 1× PBS. This result demonstrates that the membrane sensors can 
generate stable and reliable signals in response to the lactate concentration in human plasma.  
When detecting lactate in 1× PBS, the oxygen peak vanished after 1 mM. However, in 
Figure 4.7a, there are two peaks in the two nethermost grams, one at -0.4 V which is defined 
as the oxygen peak as discussed previously and the other at -0.6 V which is the H2O2 peak. In 
another word, oxygen interfering is more pronounced in human plasma compared to that in 
PBS.   
4.8.2 Lactate Detection in Human Whole Blood 
The lactate detection in whole blood was conducted in the SED, and all the experimental 
procedures and settings of DPV were the same as introduced before. The testing solutions 
were prepared according to the table in Appendix A.   
Figure 4.8. The DPV grams of one membrane sensor immersed in human whole blood with 




Using the membrane sensors to detect lactate in human whole blood turns out to be more 
challenging. Although this experiment has been repeated many times, the set of DPV grams in 
Figure 4.8 is the only set of data where the H2O2 peak does increase with the lactate 
concentration. Moreover, in this case, when the spiked lactate concentration became larger 
than 15 mM, the H2O2 peak stopped increasing. Other trials provided more disordered results: 
when the lactate concentration was increased, the H2O2 peak could decrease or stay the same.  
There are two drawbacks of using the membrane sensors to detect lactate in whole 
blood: 1) the linear detection range is likely to be narrower; 2) the sensors cannot produce 
repeatable data. Since there are a large number of cells in whole blood, the blood cells are 
suspected to significantly disturb the membrane sensors. During lactate detection, cells could 
hinder the oxygen and lactate molecules from approaching the WE surface. After the first 
scan of DPV and the membrane sensors were taken out of the blood sample, it was observed 
that some blood residue remained on the surface of the enzyme matrix or even inside it and 
could not be rinsed away. It is possible that some reactions or interactions had taken place 
between the cells and the enzyme matrix during the DPV scan. After that, the enzyme matrix 
might have been affected and could not function normally. Since the membrane sensors 
cannot be used in whole blood for multiple times, it is impossible to generate a calibration 
curve. However, a single DPV scan of the sensor in blood is considered to be reliable. 
4.8.3 Comparisons among PBS, Plasma and Blood 
To understand how the electrolyte solution affects the signal generated by the membrane 
sensors, the DPV grams of 10 mM lactate were generated in 2 mL 1× PBS, human plasma 
and whole blood in sequence in a beaker by the same membrane sensor. This membrane 
sensor was tested in one solution, fully rinsed by Milli-Q water, dabbed to dry, and then tested 
in the others. Blood was the last one to be tested since the membrane sensor became 




One set of the DPV grams is presented in Figure 4.9. Firstly, it is obvious that although 
the lactate concentrations in three sample solutions are the same, the three Ip values produced 
by the same membrane sensor differ from each other. The peak with the maximum height 
appears in 1×PBS while the peak in blood is the smallest one. To be more precise, the 
absolute values of Ip of 10 mM lactate in 1× PBS, plasma and blood are listed in Table 4.2. To 
explain why the Ip of 10 mM lactate varies in the three types of electrolyte solutions, the 
properties of these solutions should be discussed. Human whole blood is composed of red 
cells, white cells, platelets and plasma. There are some proteins in plasma while there are only 
ions in PBS. When they are used as the electrolyte solution of an electrochemical cell, their 
viscosity is the most concerned parameter.   
Ip of a CV gram is inversely proportional to the square root of the viscosity of the 
electrolyte solution. According to the Equation 3.1 and 3.2, Ip is always proportional to the 
square root of D, the diffusion constant of the reactant. According to the Stokes-Einstein 
equation, D is inversely proportional to the viscosity of the medium (η), which is the 




                                                4.3 
where KB is Boltzmann's constant, T is absolute temperature the and r is the radius of the 
reactant if considering it as a spherical particle.  
Figure 4.9. The DPV grams of one membrane sensor in 2 mL 1× PBS, human plasma and 





The conductivity of the electrolyte solution could alter the signal as well. There is no 
parameter in both Equation 3.1 and 3.2 that is directly related to the conductivity, since the 
equations consider the electrolyte solution to be ideal, which means, highly conductive. The 
large number of free ions in the electrolyte solution ensure the instant compensation of the 
charge created by the electron transfer between the electrode and the analyte.106 They also 
help prevent the migration of the analyte.106 When the electrolyte solution is not conductive 
enough, the charge compensation might become inefficient and the negative WE would repel 
the negatively charged lactate molecules, leading to the decrease of the Ip. 
The dynamic viscosity values of 1× PBS, human plasma and whole blood, were 
collected from the literature.107–109 Their conductivities were determined in the lab using the 
conductivity meter from VWR at 25 ℃. All these values are summarized in the following 
table: 
  
1× PBS Plasma Blood 
Viscosity at 37 ℃ (cP) 0.7 1.2 4.4 
Conductivity at 25 ℃ (S/m) 1.32 1.02 0.51 







Table 4.2. The viscosity and conductivity values of 1× PBS, human plasma and whole 
blood.107–109 The values of Ip generated by the membrane sensors in these three sample 
solutions that were spiked with 10 mM lactate. 
 
As shown in Table 4.2, blood has the highest dynamic viscosity which is about 6.3 and 
3.7 times more than that of 1× PBS and plasma, respectively. Meanwhile, 1× PBS has the 
largest conductivity, which is about 1.3 and 2.6 times more than that of plasma and blood. 
According to the effects of electrolyte conductivity and viscosity on Ip, the membrane sensors 
should generate the largest Ip in 1× PBS, and the smallest Ip in blood. Our experimental result 
is consistent with the theoretical deduction. 
The second difference among the three DPV grams is the peak potential. The peak 
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potentials in both plasma and blood are more negative than that in PBS. This might indicate 
that plasma and blood have similar Cl- concentration, while both have a less Cl- concentration 





Chapter 5. Glucose Biosensor 
5.1 Introduction of Glucose Monitoring 
As stated previously, glucose is another essential analyte in the human body. In fact, 
since diabetes mellitus affects a large population all over the world, glucose biosensors 
command over 80 % of the biosensor market.110 To realize the daily and convenient 
monitoring of glucose for diabetics, the glucose biosensor was firstly commercialized by 
Yellow Springs Instrument Company (YSI; Yellow Springs, Ohio, USA) in 1975.91 Since 
then, glucose biosensors have been the greatest interest of the researchers who investigate 
biosensors. As a result, in this work, we simply replaced LOD with glucose oxidase (GOD) to 
see if our membrane sensor could detect glucose.  
The same as lactate, glucose has two forms, D-glucose and L-glucose. The glucose 
discussed in this work is D-glucose since glucose naturally exist in this form. Glucose can 
present in two structures, the chain form and the ring form, and these two structures are 
presented in the following figure:111  
The principle of the glucose detection in this work was almost the same as the lactate 
detection. Two consequent reactions take place on the surface of the WE: 
𝐺𝑙𝑢𝑐𝑜𝑠𝑒 + 𝑂2
𝐺𝑂𝐷
→  𝐺𝑙𝑢𝑐𝑜𝑛𝑖𝑐 𝑎𝑐𝑖𝑑 + 𝐻2𝑂2                                  5.1 
𝐻2𝑂2 + 2𝐻
+ + 2𝑒− → 2𝐻2𝑂                                              5.2 





Firstly, by the catalyzation of glucose oxidase, glucose is oxidized and H2O2 is produced. 
H2O2 is then reduced because of the potential applied onto the WE and the current signal that 
represent the concentration of glucose can be detected by the membrane sensor.  
5.2 Glucose Detection in Plasma 
GOD lyophilized powder and D-(+)-glucose powder were purchased from Sigma 
Aldrich. 20 mg/ml GOD solution was prepared with 1× PBS. The immobilization of GOD on 
the WE, with the assistance of GA and BSA, followed the same procedure as the 
immobilization of LOD. Sample solutions for the glucose detection in plasma were prepared 
according to the table in Appendix B. The membrane sensors were placed inside the SED for 
the glucose detection. All the experimental procedures and the settings of DPV stayed 
unchanged as introduced before.   
Judging from the results shown in Figure 5.2, our membrane sensors are able to detect 
glucose in human plasma. As can be seen from the DPV grams in Figure 5.1a, stable signals 
are recorded by the membrane sensor. There is a defined peak at about -0.65 V, which results 
from the reduction of H2O2. This peak rises as the glucose concentration in the plasma is 
elevated. The calibration curve is shown in Figure 5.1b. As the spiked glucose concentration 
increased from 5 mM to 25 mM, the membrane sensors provide a linear response in terms of 
the logarithmic concentration values. The normal glucose level in the human whole blood is 
Figure 5.2. (a) The DPV grams of one membrane sensor immersed in human blood plasma 
with different glucose concentrations in the SED. (b) The calibration curve of the membrane 






generally higher than that of lactate, which is 3.9-6.2 mM at fasting state and 3.9-7.8 mM at 2 
h after meal.112 If the initial glucose concentration in human plasma is assumed to be 5 mM, 
our membrane sensors would have a dynamic response range towards the glucose 
concentration in human plasma from 10 to 30 mM. 
For both lactate and glucose detections, although Ip increases with the analyte 
concentration, the absolute value of Ip differs for two systems. When the concentration of the 
analyte in human plasma increases from 5 mM to 30 mM, the lactate signal rises by about 0.7 
μA while the glucose signal rises by only 0.2 μA. In this case, the efficiency difference 
between the two enzymatic reactions is likely to lead to the different growing rates of Ip. 
According to the information provided by the vendors, the GOD activity is 100-250 units/mg 
and its molecular weight is 160 kDa; the LOD activity is 20-60 units/mg and its molecular 
weight is 80 kDa. Since the masses of the two enzymes on the WE are the same, the molar 
ratio between GOD and LOD is 1:2. The molar activity of the GOD and LOD can be 
calculated as 1.6×1010- 4×1011 units/mol and 1.6×109- 4.8×109 units/mol. As a result, if both 
GOD and LOD are ideally immobilized and preserved on the electrode surface, glucose 
oxidation will be more efficient than lactate oxidation. This cannot explain our results, but it 
is possible that the amount of active LOD in this particular immobilizing matrix is higher than 
that of active GOD. The other reasonable explanation is the different diffusion rates of 
glucose and lactate molecules in human plasma. Generally speaking, the diffusion rate of a 
particle is inversely proportional to its molecular weight. Glucose is 180.16 g/mol and lactate 
has a molecular weight of 89.08 g/mol. As a result, lactate is likely to diffuse faster than 
glucose in human plasma and generate a stronger signal. According to our results, the rate-
determining step on the WE surface is the mass transport of the analytes instead of the 




Chapter 6. Summary and Future Work 
Lactate is an essential health indicator and its precise monitoring is required. To simplify 
the process of the lactate monitoring in the human body, capillary blood and ISF, instead of 
whole blood, can be extracted as the sample to be detected. The extraction of the desired body 
fluids can be accomplished by microneedles. After the sample collection, electrochemical 
biosensors provide a simple and reliable method to detect the level of lactate. In this thesis, a 
lactate biosensor was developed and combined with a transdermal microneedle patch to 
present the whole process of lactate monitoring in the human body, from the sample 
collection to its detection. 
The fabrication of the lactate biosensor was presented in detail in Chapter 2. This 
biosensor consisted of three electrodes, which was RE, WE and CE, respectively. The 
electrodes were made of gold, which were deposited on vinyl paper by EB-PVD. To fabricate 
the RE, which was a solid-state Ag/AgCl electrode, the electrochemical deposition of silver 
and the partial chlorination of silver were performed. On the surface of WE, LOD was 
immobilized by GA in company with BSA. In this way, the enzyme activity was kept and the 
diffusion of LOD to the sample solution was prevented.  
In Chapter 3, the principles of CV and DPV, which were the approaches used to 
characterize the lactate biosensor, were introduced. The relation between the peak in CV that 
and the lactate concentration was determined by a standard electrode system. After that, the 
fabricated lactate membrane biosensors were tested in PBS with various lactate 
concentrations. The CV grams of the biosensors also presented the targeted peak and a 
dynamic detection range of 4 to 30 mM was acquired. 
In Chapter 4, the fabrication and purpose of the SED were presented. The transdermal 
patch and the lactate biosensor were assembled together inside the SED. The sample to be 
detected was pumped into the device through the microneedles to immerse the biosensor. 
Inside the device, although there was a small amount of test solution and a large pressure 
applied to the lactate sensor, it could function the same as it did in the beakers. Real body 
51 
 
fluid samples, human plasma and whole blood, were used to test the lactate biosensor. It 
turned out that the sensor could generate reliable signals in plasma while not in whole blood. 
In Chapter 5, a glucose biosensor was fabricated by simply replacing the LOD on the 
WE surface by GOD. This glucose biosensor could sensitively response to the glucose 
concentration in human plasma from 10 to 30 mM when assembled inside the SED. 
The lactate biosensor developed and tested in this thesis was based on a simple 
configuration. To realize the practical use of this membrane biosensor, it is required to be 
modified and improved in many aspects.  
First of all, it must be able to conduct detection in whole blood samples. The most direct 
solution that we proposed is to place a filter between the transdermal patch and the lactate 
biosensor. This filter should be able to filter out the blood cells and thus only plasma can 
reach the sensor. However, common filter membranes, including those made of poly(ether 
sulfones), polycarbonate, glass fiber and cellulose, were unable to meet our requirement. 
When they were used to separate blood cells and plasma, cells could be easily broken if a 
pressure was applied to push the liquid through, or the pores could be clogged by cells and 
nothing could come out at the other side if no pressure was applied. Up to now, one product, 
called blood separator, is the most potential candidate. It is a thick and hydrophilic paper with 
a highly porous structure. When blood is dropped onto it, blood can be absorbed and migrates 
inside the paper. This product separates plasma from whole blood since plasma travels further 
than the cells inside it. In the SED, we made another chamber for the blood separator, which 
was located between the transdermal patch and the lactate biosensor (a picture of the set-up is 
shown in Appendix C). In this chamber, the blood separator was rolled like a roll paper. A 
syringe pump was used to pump about 1.5 mL of whole blood into the device at a constant 
and slow speed. After a few minutes, we observed plasma (with some blood cells) in the 
upper chamber whose volume was adequate for the biosensor to detect lactate. Preliminary 
results demonstrated the feasibility of using the blood separator to collect a relatively large 
volume of plasma from whole blood, but further modifications should be made to minimize 
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the volume of whole blood required.  
Since we want the membrane sensor to detect the lactate level in human body every 5 
minutes for at least 8 hours, the stability of the sensor should be improved, and the sensor 
lifetime requires to be elongated.  
The stability of the reference electrode greatly influences the sensor lifetime. As 
discussed before, the solid-state Ag/AgCl electrode fabricated in this thesis could not keep 
stable for a long time. Covering the electrode with a gel rich in Cl- as mentioned in section 
2.2.1 is worth trying. Other methods of making the solid-state Ag/AgCl electrode are possible 
to generate more stale electrodes. More literature research about other types of solid-state 
reference electrodes is required to find a solid-state reference electrode that is intrinsically 
more stable than the solid-state Ag/AgCl electrode. 
Besides the reference electrode, the enzyme electrode is an essential factor that affects 
not only the stability of the biosensor but also the sensitivity of the signal. Some 
nanostructures could be introduced onto the surface of the WE; For example, a silver layer 
with nano-structures could be generated on the WE surface. In this way, the surface area of 
the electrode will be enlarged sharply; more enzymes could be immobilized close to the 
electrode and this kind of structure is beneficial to keep the enzymes active. In the enzyme 
immobilizing matrix, more nanomaterials could be added, such as carbon nanotubes. 
Conducting nanomaterials could facilitate the electron transfer within the matrix and enhance 
the sensitivity of the signal. Other enzyme immobilization methods, such as immobilizing 
enzymes into hydrogel, are worth trying. To evaluate the efficiency of various enzyme 
immobilization methods, one can perform two measurements. The first is to quantify the 
number of proteins that are actually bounded in the matrix. Some well-developed assays, such 
as Bradford assay, can be used to accurately determine the number of proteins. The number of 
immobilized proteins can be determined by getting the difference between the numbers of 
total proteins and unbounded proteins. The second step of evaluation is to quantify the 
activity of the immobilized enzyme. We can use established colorimetric assays to determine 
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enzyme activity. For example, for LOD, there is a well-established assay from Sigma-Aldrich 
to quantify its activity.113 This assay uses the absorbance of the final product to represent the 
activity of LOD. The enzymes can be immobilized on the bottom of the wells of a 96-well 
plates, using the same crosslinking condition for enzyme immobilization on sensor electrodes. 
Since the enzymes cannot diffuse freely in the solution, it is necessary to make some 








1. Hao, Y. & Foster, R. Wireless body sensor networks for health-monitoring 
applications. Physiological Measurement (2008).  
2. Wang, X., Liu, Z. & Zhang, T. Flexible Sensing Electronics for Wearable/Attachable 
Health Monitoring. Small 13, (2017). 
3. Bandodkar, A. J. & Wang, J. Non-invasive wearable electrochemical sensors: A 
review. Trends in Biotechnology (2014).  
4. Patel, S., Park, H., Bonato, P., Chan, L. & Rodgers, M. A review of wearable sensors 
and systems with application in rehabilitation. Journal of NeuroEngineering and 
Rehabilitation (2012).  
5. Tierney, M. J., Tamada, J. A., Potts, R. O., Jovanovic, L. & Garg, S. Clinical 
evaluation of the GlucoWatch® biographer: A continual, non-invasive glucose monitor 
for patients with diabetes. in Biosensors and Bioelectronics (2001).  
6. Yang, Y. L., Chuang, M. C., Lou, S. L. & Wang, J. Thick-film textile-based 
amperometric sensors and biosensors. Analyst (2010).  
7. Kim, J. et al. Wearable smart sensor systems integrated on soft contact lenses for 
wireless ocular diagnostics. Nat. Commun. (2017).  
8. Yeo, W. H. et al. Multifunctional epidermal electronics printed directly onto the skin. 
Adv. Mater. (2013).  
9. Kabiri Ameri, S. et al. Graphene Electronic Tattoo Sensors. ACS Nano (2017).  
10. Pantelopoulos, A. & Bourbakis, N. G. A survey on wearable sensor-based systems for 
health monitoring and prognosis. IEEE Transactions on Systems, Man and Cybernetics 
Part C: Applications and Reviews (2010).  
11. Takei, K., Honda, W., Harada, S., Arie, T. & Akita, S. Toward flexible and wearable 
human-interactive health-monitoring devices. Adv. Healthc. Mater. 4, 487–500 (2015). 
12. Bandodkar, A. J. et al. Tattoo-based potentiometric ion-selective sensors for epidermal 
pH monitoring. Analyst 138, 123–128 (2013). 
13. Bandodkar, A. J. et al. Epidermal tattoo potentiometric sodium sensors with wireless 
signal transduction for continuous non-invasive sweat monitoring. Biosens. 
Bioelectron. 54, 603–609 (2014). 
14. Guinovart, T., Bandodkar, A. J., Windmiller, J. R., Andrade, F. J. & Wang, J. A 
potentiometric tattoo sensor for monitoring ammonium in sweat. Analyst 138, 7031 
(2013). 
15. Yang, S. et al. ‘cut-and-Paste’ Manufacture of Multiparametric Epidermal Sensor 
Systems. Adv. Mater. (2015).  
55 
 
16. Gao, W. et al. Fully integrated wearable sensor arrays for multiplexed in situ 
perspiration analysis. Nature (2016).  
17. Clark, L. C. & Lyons, C. Electrode systems for continuous monitoring in 
cardiovascular surgery. Ann. N. Y. Acad. Sci. 102, 29–45 (1962). 
18. Eggins, B. Chemical Sensors and Biosensors. Chemical Sensors and Biosensors 
(2007).  
19. Grieshaber, D., MacKenzie, R., Vörös, J. & Reimhult, E. Electrochemical Biosensors - 
Sensor Principles and Architectures. Sensors 8, 1400–1458 (2008). 
20. Scheller, F. W. et al. Biosensors: trends and commercialization. Biosensors (1985).  
21. Singh, M., Verma, N., Garg, A. K. & Redhu, N. Urea biosensors. Sensors and 
Actuators, B: Chemical 134, 345–351 (2008). 
22. Chen, C. et al. Recent advances in electrochemical glucose biosensors. RSC Adv. 3, 
4473–4491 (2013). 
23. Rassaei, L., Olthuis, W., Tsujimura, S., Sudhölter, E. J. R. & Van Den Berg, A. Lactate 
biosensors: Current status and outlook. Analytical and Bioanalytical Chemistry 406, 
123–137 (2014). 
24. Mandel, A. & Lusk, G. Lactic acid in intermediary metabolism. Am. J. Physiol. 16, 
129–146 (1906). 
25. Allen, S. E. & Holm, J. L. Lactate: Physiology and clinical utility. J. Vet. Emerg. Crit. 
Care 18, 123–132 (2008). 
26. Madias, N. E. Lactic acidosis. Kidney Int. 29, 752–774 (1986). 
27. Yudkin, J. & Cohen, R. D. The contribution of the kidney to the removal of a lactic 
acid load under normal and acidotic conditions in the conscious rat. Clin. Sci. Mol. 
Med. (1975). 
28. Pyne, D. B., Boston, T., Martin, D. T. & Logan, A. Evaluation of the Lactate Pro blood 
lactate analyser. Eur. J. Appl. Physiol. 82, 112–116 (2000). 
29. Derbyshire, P. J., Barr, H., Davis, F. & Higson, S. P. J. Lactate in human sweat: A 
critical review of research to the present day. Journal of Physiological Sciences 62, 
429–440 (2012). 
30. Faude, O., Kindermann, W. & Meyer, T. Lactate threshold concepts: How valid are 
they? Sports Medicine 39, 469–490 (2009). 
31. Mizock, B. A. & Falk, J. L. Lactic acidosis in critical illness. in Critical Care 
Medicine (1992).  
32. Tanner, R. K., Fuller, K. L. & Ross, M. L. R. Evaluation of three portable blood lactate 




33. Bonaventura, J. M. et al. Reliability and accuracy of six hand-held blood lactate 
analysers. J. Sport. Sci. Med. 14, 203–214 (2014). 
34. Chen, Q. et al. Flexible electrochemical biosensors based on graphene nanowalls for 
the real-time measurement of lactate. Nanotechnology 28, 315501 (2017). 
35. Lei, Y. et al. A highly sensitive electrochemical biosensor based on zinc oxide 
nanotetrapods for l-lactic acid detection. Nanoscale 4, 3438–3443 (2012). 
36. Hernández-Ibáñez, N. et al. Electrochemical lactate biosensor based upon 
chitosan/carbon nanotubes modified screen-printed graphite electrodes for the 
determination of lactate in embryonic cell cultures. Biosens. Bioelectron. 77, 1168–
1174 (2016). 
37. Jia, W. et al. Electrochemical tattoo biosensors for real-time noninvasive lactate 
monitoring in human perspiration. Anal. Chem. 85, 6553–6560 (2013). 
38. Pohanka, M. & Republic, C. Electrochemical biosensors – principles and applications. 
Methods (2008). 
39. Waleed Shinwari, M. et al. Microfabricated reference electrodes and their biosensing 
applications. Sensors (2010).  
40. Rassaei, L., Olthuis, W., Tsujimura, S., Sudhölter, E. J. R. & van den Berg, A. Lactate 
biosensors: current status and outlook. Anal. Bioanal. Chem. 406, 123–137 (2014). 
41. D. A. McQuarrie, P. A. Rock,  and E. B. G. General chemistry,4th ed. 
42. Hickey, D. P., Reid, R. C., Milton, R. D. & Minteer, S. D. A self-powered 
amperometric lactate biosensor based on lactate oxidase immobilized in 
dimethylferrocene-modified LPEI. Biosens. Bioelectron. (2016).  
43. Malon, R. S. P., Chua, K. Y., Wicaksono, D. H. B. & Córcoles, E. P. Cotton fabric-
based electrochemical device for lactate measurement in saliva. Analyst (2014).  
44. Menten, L. & Michaelis, M. Kinetics of invertase action. Biochem Z 49, 333–369 
(1913). 
45. Thomas Shafee. Saturation curve for an enzyme reaction showing the relation between 
the substrate concentration and reaction rate. (2015). Available at: 
https://commons.wikimedia.org/wiki/File:Michaelis_Menten_curve_2.svg.  
46. Singh, J. & Wolfe, D. E. Review Nano and macro-structured component fabrication by 
electron beam-physical vapor deposition (EB-PVD). J. Mater. Sci. 40, 1–26 (2005). 
47. Singh, J. & Wolfe, D. E. Nanostructured component fabrication by electron beam-
physical vapor deposition. in Journal of Materials Engineering and Performance 
(2005).  
48. Singh, J., Quli, F., Wolfe, D. E. & Schriempf, J. An Overview: Electron Beam-
Physical Vapor Deposition Technology-Present and Future Applications. Surf. Eng. 
57 
 
Sci. Technol. I (1999).  
49. Wolfe, D. E., Singh, J. & Narasimhan, K. Synthesis and characterization of 
multilayered TiC/TiB2coatings deposited by ion beam assisted, electron beam-
physical vapor deposition (EB-PVD). Surf. Coatings Technol. (2003).  
50. Sarma, A. K., Vatsyayan, P., Goswami, P. & Minteer, S. D. Recent advances in 
material science for developing enzyme electrodes. Biosensors and Bioelectronics 24, 
2313–2322 (2009). 
51. Guo, S., Wen, D., Zhai, Y., Dong, S. & Wang, E. Platinum nanoparticle ensemble-on-
graphene hybrid nanosheet: One-pot, rapid synthesis, and used as new electrode 
material for electrochemical sensing. ACS Nano 4, 3959–3968 (2010). 
52. Pingarrón, J. M., Yáñez-Sedeño, P. & González-Cortés, A. Gold nanoparticle-based 
electrochemical biosensors. Electrochim. Acta 53, 5848–5866 (2008). 
53. Zhang, S., Wang, N., Yu, H., Niu, Y. & Sun, C. Covalent attachment of glucose 
oxidase to an Au electrode modified with gold nanoparticles for use as glucose 
biosensor. Bioelectrochemistry 67, 15–22 (2005). 
54. Shelley D. Minteer. Microfluidic Techniques: Reviews and Protocols. (2006). 
55. Hamann, C. H., Hamnett, A. & Vielstich, W. Electrochemistry. Wiley-VCH Verlag 
GmbH & Co. KGaA (2007).  
56. Kim, T. Y., Hong, S. A. & Yang, S. A solid-state thin-film Ag/AgCl reference electrode 
coated with graphene oxide and its use in a pH sensor. Sensors (Switzerland) (2015).  
57. Noh, J., Park, S., Boo, H., Kim, H. C. & Chung, T. D. Nanoporous platinum solid-state 
reference electrode with layer-by-layer polyelectrolyte junction for pH sensing chip. 
Lab Chip (2011).  
58. Polk, B. J., Stelzenmuller, A., Mijares, G., MacCrehan, W. & Gaitan, M. Ag/AgCl 
microelectrodes with improved stability for microfluidics. Sensors Actuators B Chem. 
114, 239–247 (2006). 
59. Moussy, F. & Harrison, D. J. Prevention of the Rapid Degradation of Subcutaneously 
Implanted Ag/AgCl Reference Electrodes Using Polymer Coatings. Anal. Chem. 66, 
674–679 (1994). 
60. Huang, I. Y. & Huang, R. S. Fabrication and characterization of a new planar solid-
state reference electrode for ISFET sensors. Thin Solid Films (2002).  
61. Liao, W. Y. & Chou, T. C. Fabrication of a planar-form screen-printed solid electrolyte 
modified Ag/AgCl reference electrode for application in a potentiometric biosensor. 
Anal. Chem. (2006). 
62. Polk, B. J., Stelzenmuller, A., Mijares, G., MacCrehan, W. & Gaitan, M. Ag/AgCl 




63. Cranny, A. W. J. & Atkinson, J. K. Thick film silver – silver chloride reference 
electrodes. Solutions (1998).  
64. Suzuki, H., Hiratsuka, A., Sasaki, S. & Karube, I. Problems associated with the thin-
film Ag/AgCl reference electrode and a novel structure with improved durability. 
Sensors Actuators B Chem. 46, 104–113 (1998). 
65. Almeida, F. L. et al. Fabrication Process of Ag/AgCl Reference Pseudo-Electrode 
Based on Electrodeposition of Au on Pt Surfaces from Formaldehyde Baths: Chemical 
Stability and Adherence. in ECS Transactions (2009).  
66. Sassolas, A., Blum, L. J. & Leca-Bouvier, B. D. Immobilization strategies to develop 
enzymatic biosensors. Biotechnology Advances 30, 489–511 (2012). 
67. Sassolas, A., Blum, L. J. & Leca-Bouvier, B. D. Immobilization strategies to develop 
enzymatic biosensors. Biotechnology Advances (2012).  
68. Campàs, M., Bucur, B., Andreescu, S. & Marty, J.-L. Application of oriented 
immobilisation to enzyme sensors. Curr Top Biotechnol 1, (2004). 
69. Wang, J. Carbon-nanotube based electrochemical biosensors: A review. 
Electroanalysis 17, 7–14 (2005). 
70. Luo, X., Morrin, A., Killard, A. J. & Smyth, M. R. Application of nanoparticles in 
electrochemical sensors and biosensors. Electroanalysis (2006).  
71. Bowes, J. H. & Cater, C. W. The interaction of aldehydes with collagen. BBA - Protein 
Struct. (1968). 
72. Habeeb, A. F. S. A. & Hiramoto, R. Reaction of proteins with glutaraldehyde. Arch. 
Biochem. Biophys. (1968). 
73. Avrameas, S. & Ternynck, T. The cross-linking of proteins with glutaraldehyde and its 
use for the preaparation of immunoadsorbernts. Immunochemistry (1969).  
74. Migneault, I., Dartiguenave, C., Bertrand, M. J. & Waldron, K. C. Glutaraldehyde: 
Behavior in aqueous solution, reaction with proteins, and application to enzyme 
crosslinking. BioTechniques (2004). 
75. Crespilho, F. N. et al. A strategy for enzyme immobilization on layer-by-layer 
dendrimer-gold nanoparticle electrocatalytic membrane incorporating redox mediator. 
Electrochem. commun. (2006).  
76. De Luca, S. et al. Carbon film electrodes for oxidase-based enzyme sensors in food 
analysis. in Talanta (2005).  
77. Fiorito, P. A., Brett, C. M. A. & Córdoba De Torresi, S. I. Polypyrrole/copper 
hexacyanoferrate hybrid as redox mediator for glucose biosensors. in Talanta (2006).  
78. Islan, G. A., Martinez, Y. N., Illanes, A. & Castro, G. R. Development of novel 
59 
 
alginate lyase cross-linked aggregates for the oral treatment of cystic fibrosis. RSC 
Adv. (2014).  
79. Brownson, D. A. C. & Banks, C. E. The Handbook of Graphene Electrochemistry. The 
Handbook of Graphene Electrochemistry (2014). 
80. Kissinger, P. T. & Heineman, W. R. Cyclic voltammetry. J. Chem. Educ. 60, 702 
(1983). 
81. Shrivastava, A. & Gupta, V. B. Methods for the determination of limit of detection and 
limit of quantitation of the analytical methods. 2, 21–25 (2011). 
82. Mannoor, M. S. et al. Graphene-based wireless bacteria detection on tooth enamel. 
Nat. Commun. 3, 763 (2012). 
83. Chu, M. X. et al. Soft contact lens biosensor for in situ monitoring of tear glucose as 
non-invasive blood sugar assessment. Talanta 83, 960–965 (2011). 
84. Mishra, R. K., Vinu Mohan, A. M., Soto, F., Chrostowski, R. & Wang, J. A 
microneedle biosensor for minimally-invasive transdermal detection of nerve agents. 
Analyst 142, 918–924 (2017). 
85. Emaminejad, S. et al. Autonomous sweat extraction and analysis applied to cystic 
fibrosis and glucose monitoring using a fully integrated wearable platform. Proc. Natl. 
Acad. Sci. 114, 4625–4630 (2017). 
86. Sabat, J. et al. The use of finger-stick blood to assess lactate in critically ill surgical 
patients. Ann. Med. Surg. 10, 41–48 (2016). 
87. Petersen, L. J. Interstitial lactate levels in human skin at rest and during an oral 
glucose load: a microdialysis study. Clin. Physiol. 19, 246–250 (1999). 
88. Tobin, D. J. Biochemistry of human skin—our brain on the outside. Chem. Soc. Rev. 
35, 52–67 (2006). 
89. Ventrelli, L., Marsilio Strambini, L. & Barillaro, G. Microneedles for Transdermal 
Biosensing: Current Picture and Future Direction. Adv. Healthc. Mater. 4, 2606–2640 
(2015). 
90. Roe, J. N. & Smoller, B. R. Bloodless glucose measurements. Crit.Rev.Ther.Drug 
Carr. Syst. 15, 199–241 (1998). 
91. Setford, S. J. & Newman, J. D. Enzyme Biosensors. Microbial Enzymes and 
Biotransformations 17, (2005). 
92. Khanna, P., Strom, J. A., Malone, J. I. & Bhansali, S. Microneedle-Based Automated 
Therapy for Diabetes Mellitus. J. Diabetes Sci. Technol. 2, 1122–1129 (2008). 
93. Prausnitz, M. R. Microneedles for transdermal drug delivery. Advanced Drug Delivery 
Reviews 56, 581–587 (2004). 
94. Henry, S., McAllister, D. V., Allen, M. G. & Prausnitz, M. R. Microfabricated 
60 
 
microneedles: A novel approach to transdermal drug delivery. J. Pharm. Sci. 87, 922–
925 (1998). 
95. Smart, W. H. & Subramanian, K. The use of silicon microfabrication technology in 
painless blood glucose monitoring. Diabetes Technol. Ther. (2000).  
96. Sivamani, R. K., Liepmann, D. & Maibach, H. I. Microneedles and transdermal 
applications. Expert Opin. Drug Deliv. 4, 19–25 (2007). 
97. Matsuda, T. & Mizutani, M. Liquid acrylate-endcapped biodegradable poly(ε-
caprolactone-co-trimethylene carbonate). II. Computer-aided stereolithographic 
microarchitectural surface photoconstructs. J. Biomed. Mater. Res. (2002).  
98. Park, J. H., Allen, M. G. & Prausnitz, M. R. Biodegradable polymer microneedles: 
Fabrication, mechanics and transdermal drug delivery. J. Control. Release (2005).  
99. Miyano, T. et al. Sugar micro needles as transdermic drug delivery system. Biomed. 
Microdevices (2005).  
100. Park, J. H., Allen, M. G. & Prausnitz, M. R. Polymer microneedles for controlled-
release drug delivery. Pharm. Res. (2006).  
101. Gill, H. S., Denson, D. D., Burris, B. A. & Prausnitz, M. R. Effect of Microneedle 
Design on Pain in Human Volunteers. Clin. J. Pain 24, 585–594 (2008). 
102. Yousif, M. Y., Holdsworth, D. W. & Poepping, T. L. A blood-mimicking fluid for 
particle image velocimetry with silicone vascular models. Exp. Fluids 50, 769–774 
(2011). 
103. Kirby, B. J. Micro- and Nanoscale Fluid Mechanics: Transport in Microfluidic 
Devices. Brian (2010).  
104. Shore, A. C., Sandeman, D. D. & Tooke, J. E. Capillary pressure, pulse pressure 
amplitude, and pressure waveform in healthy volunteers. Am. J. Physiol. Circ. Physiol. 
268, H147–H154 (1995). 
105. Kholodenko, A. L. & Douglas, J. F. Generalized Stokes-Einstein equation for spherical 
particle suspensions. Phys. Rev. E (1995).  
106. Elgrishi, N. et al. A Practical Beginner’s Guide to Cyclic Voltammetry. J. Chem. Educ. 
(2017).  
107. Soenksen, L. R., Kassis, T., Noh, M., Griffith, L. G. & Trumper, D. L. Closed-loop 
feedback control for microfluidic systems through automated capacitive fluid height 
sensing. Lab Chip (2018). 
108. Késmárky, G., Kenyeres, P., Rábai, M. & Tóth, K. Plasma viscosity: A forgotten 
variable. in Clinical Hemorheology and Microcirculation (2008). doi:10.3233/CH-
2008-1088 
109. Yousif, M. Y., Holdsworth, D. W. & Poepping, T. L. A blood-mimicking fluid for 
61 
 
particle image velocimetry with silicone vascular models. Exp. Fluids (2011).  
110. Wang, J. Electrochemical glucose biosensors. in Electrochemical Sensors, Biosensors 
and their Biomedical Applications (2008).  
111. Ben & Yikrazuul. D-glucose-chain-2D-Fischer. (2006). Available at: 
https://commons.wikimedia.org/wiki/File:D-glucose-chain-2D-
Fischer.png#/media/File:D-glucose.png.  
112. Chen, C. et al. Recent advances in electrochemical glucose biosensors: A review. RSC 
Advances (2013). 











 (Whole blood) 
0.5 M Lactate 
Solution 
1 M Lactate  
Solution 
Pure plasma 1 0 0 
5 1 0.01 0 
10 1 0 0.01 
15 1 0 0.015 
20 1 0 0.02 
25 1 0 0.025 
30 1 0 0.03 
Compositions of the sample solutions for lactate detection in plasma or whole blood. To 
increase the lactate concentration in the real body fluid, highly concentrated (0.5 M or 1 M) 






Compositions of the sample solutions for glucose detection in plasma. To increase the glucose 
concentration in pure plasma, 0.5 or 1 M glucose solution was added to the pure plasma based 
















0.5 M Glucose 
Solution 
1 M Glucose 
Solution 
Pure plasma 1 0 0 
5 1 0.01 0 
10 1 0 0.0.1 
15 1 0 0.015 
20 1 0 0.02 








A picture of the set-up to separate plasma from whole blood.  
